| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | ATP6V1B1 ABCA4 MYO6 RTEL1 ATP9B ATP8B1 ABCB1 SLC27A1 SHOC1 MLH1 DHX35 ATP13A3 ACSS3 SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 NUBP2 ORC1 MYH15 DHX34 ATP2B2 SMC1B | 1.83e-08 | 614 | 235 | 26 | GO:0140657 |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA4 RTEL1 ATP9B ATP8B1 ABCB1 SHOC1 MLH1 DHX35 ATP13A3 SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 ORC1 DHX34 ATP2B2 SMC1B | 2.99e-07 | 441 | 235 | 20 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | ABCA4 RTEL1 ATP9B RGS11 ATP8B1 RRAGC ABCB1 RRAGD SHOC1 MLH1 DHX35 ATP13A3 GNAS RAB39B SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 RGS16 GSPT1 ORC1 DHX34 ATP2B2 SMC1B | 4.94e-07 | 775 | 235 | 27 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | ABCA4 RTEL1 ATP9B RGS11 ATP8B1 RRAGC ABCB1 RRAGD SHOC1 MLH1 DHX35 ATP13A3 GNAS RAB39B SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 RGS16 GSPT1 ORC1 DHX34 ATP2B2 SMC1B | 2.25e-06 | 839 | 235 | 27 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | ABCA4 RTEL1 ATP9B RGS11 ATP8B1 RRAGC ABCB1 RRAGD SHOC1 MLH1 DHX35 ATP13A3 GNAS RAB39B SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 RGS16 GSPT1 ORC1 DHX34 ATP2B2 SMC1B | 2.30e-06 | 840 | 235 | 27 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | ABCA4 RTEL1 ATP9B RGS11 ATP8B1 RRAGC ABCB1 RRAGD SHOC1 MLH1 DHX35 ATP13A3 GNAS RAB39B SMARCA5 DDX17 TCP1 LONP2 UPF1 DDX55 XRCC5 RGS16 GSPT1 ORC1 DHX34 ATP2B2 SMC1B | 2.30e-06 | 840 | 235 | 27 | GO:0016818 |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 3.07e-04 | 28 | 235 | 4 | GO:0140326 | |
| GeneOntologyMolecularFunction | JUN kinase activity | 4.11e-04 | 3 | 235 | 2 | GO:0004705 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 5.32e-04 | 14 | 235 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | helicase activity | 5.79e-04 | 158 | 235 | 8 | GO:0004386 | |
| GeneOntologyCellularComponent | perikaryon | KLHL24 CKAP5 PDE10A NEFH CLCN2 GLRA3 GRIK4 PPP1CA WDFY3 MAPK8 MAPK9 | 4.19e-05 | 223 | 232 | 11 | GO:0043204 |
| GeneOntologyCellularComponent | ACF complex | 1.23e-04 | 2 | 232 | 2 | GO:0016590 | |
| GeneOntologyCellularComponent | nuclear chromosome | NCAPG2 SHOC1 MLH1 CARM1 SMARCA5 POLD1 POLE BRMS1L ORC1 BAZ1A SMC1B | 1.34e-04 | 254 | 232 | 11 | GO:0000228 |
| GeneOntologyCellularComponent | chromosomal region | RTEL1 CKAP5 MKI67 SMARCA5 POLD1 UPF1 XRCC5 PPP1CA PPP1CB ESCO2 ORC1 KMT5B BAZ1A SMC1B | 2.75e-04 | 421 | 232 | 14 | GO:0098687 |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 3.47e-04 | 155 | 232 | 8 | GO:0098685 | |
| GeneOntologyCellularComponent | clathrin adaptor complex | 3.68e-04 | 31 | 232 | 4 | GO:0030131 | |
| GeneOntologyCellularComponent | neuronal cell body | KLHL24 MYO6 CKAP5 PDE10A CKB NEFH TRPM5 CLCN2 GNAS PMM1 CAMK2A GLRA3 GRIK4 GRM1 PPP1CA LRP4 MAST1 WDFY3 MAPK8 MAPK9 ATP2B2 | 4.30e-04 | 835 | 232 | 21 | GO:0043025 |
| GeneOntologyCellularComponent | AP-2 adaptor complex | 4.49e-04 | 14 | 232 | 3 | GO:0030122 | |
| GeneOntologyCellularComponent | clathrin coat of endocytic vesicle | 5.56e-04 | 15 | 232 | 3 | GO:0030128 | |
| GeneOntologyCellularComponent | cell body | KLHL24 MYO6 CKAP5 PDE10A CKB NEFH TRPM5 CLCN2 GNAS PMM1 TCP1 CAMK2A GLRA3 GRIK4 GRM1 PPP1CA LRP4 MAST1 WDFY3 MAPK8 MAPK9 ATP2B2 | 7.03e-04 | 929 | 232 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | Gtr1-Gtr2 GTPase complex | 7.25e-04 | 4 | 232 | 2 | GO:1990131 | |
| GeneOntologyCellularComponent | CHRAC | 7.25e-04 | 4 | 232 | 2 | GO:0008623 | |
| GeneOntologyCellularComponent | clathrin vesicle coat | 8.12e-04 | 38 | 232 | 4 | GO:0030125 | |
| GeneOntologyCellularComponent | vesicle coat | 8.90e-04 | 67 | 232 | 5 | GO:0030120 | |
| GeneOntologyCellularComponent | somatodendritic compartment | KLHL24 CLSTN3 MYO6 CKAP5 RGS11 PDE10A CKB NEFH TRPM5 CLCN2 GNAS PMM1 SHANK1 CAMK2A FAT3 GLRA3 GRIK4 GRM1 PPP1CA LRP4 MAST1 WDFY3 CTNND1 MAPK8 MAPK9 ATP2B2 | 1.21e-03 | 1228 | 232 | 26 | GO:0036477 |
| GeneOntologyCellularComponent | endolysosome membrane | 1.34e-03 | 20 | 232 | 3 | GO:0036020 | |
| GeneOntologyCellularComponent | dendrite | CLSTN3 CKAP5 RGS11 CKB NEFH TRPM5 CLCN2 GNAS SHANK1 CAMK2A FAT3 GLRA3 GRIK4 GRM1 PPP1CA LRP4 MAST1 CTNND1 MAPK8 ATP2B2 | 1.48e-03 | 858 | 232 | 20 | GO:0030425 |
| GeneOntologyCellularComponent | dendritic tree | CLSTN3 CKAP5 RGS11 CKB NEFH TRPM5 CLCN2 GNAS SHANK1 CAMK2A FAT3 GLRA3 GRIK4 GRM1 PPP1CA LRP4 MAST1 CTNND1 MAPK8 ATP2B2 | 1.52e-03 | 860 | 232 | 20 | GO:0097447 |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 1.55e-03 | 21 | 232 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | postsynaptic specialization | CLSTN3 MYO6 LRRTM3 NEFH SHANK1 NPTX2 CAMK2A GLRA3 GRIK4 LCK GRM1 LRP4 CTNND1 ATP2B2 | 1.55e-03 | 503 | 232 | 14 | GO:0099572 |
| GeneOntologyCellularComponent | vacuolar membrane | ATP6V1B1 MYO6 RRAGC CLCN4 AP2A1 RRAGD AP2A2 AP1B1 AP2B1 BST2 MIOS DNAJC13 WDFY3 STARD3NL | 1.67e-03 | 507 | 232 | 14 | GO:0005774 |
| GeneOntologyCellularComponent | AP-type membrane coat adaptor complex | 1.96e-03 | 48 | 232 | 4 | GO:0030119 | |
| Domain | ARM-type_fold | MON2 TRPC4AP CKAP5 HSPBP1 NCAPG2 AP2A1 AP2A2 AP1B1 AP2B1 NBEAL2 KPNB1 DNAJC13 RANBP6 FMNL3 PELP1 WDFY3 CTNND1 | 1.25e-06 | 339 | 232 | 17 | IPR016024 |
| Domain | ARM-like | MON2 CKAP5 HSPBP1 NCAPG2 AP2A1 AP2A2 AP1B1 AP2B1 NBEAL2 KPNB1 DNAJC13 RANBP6 PELP1 WDFY3 CTNND1 | 1.52e-06 | 270 | 232 | 15 | IPR011989 |
| Domain | Coatomer/calthrin_app_sub_C | 1.56e-06 | 8 | 232 | 4 | IPR009028 | |
| Domain | Alpha_adaptinC2 | 2.78e-06 | 9 | 232 | 4 | PF02883 | |
| Domain | Alpha_adaptinC2 | 2.78e-06 | 9 | 232 | 4 | SM00809 | |
| Domain | Clathrin_a/b/g-adaptin_app_Ig | 2.78e-06 | 9 | 232 | 4 | IPR008152 | |
| Domain | - | MON2 CKAP5 HSPBP1 NCAPG2 AP2A1 AP2A2 AP1B1 AP2B1 KPNB1 DNAJC13 RANBP6 WDFY3 CTNND1 | 4.34e-06 | 222 | 232 | 13 | 1.25.10.10 |
| Domain | Coatomer/clathrin_app_Ig-like | 1.06e-05 | 12 | 232 | 4 | IPR013041 | |
| Domain | Adaptin_N | 2.84e-05 | 15 | 232 | 4 | PF01602 | |
| Domain | Clathrin/coatomer_adapt-like_N | 2.84e-05 | 15 | 232 | 4 | IPR002553 | |
| Domain | P-loop_NTPase | ATP6V1B1 ABCA4 MYO6 RTEL1 RRAGC ABCB1 RRAGD NLRC5 DHX35 GNAS RAB39B MYO18B SMARCA5 DDX17 LONP2 MTHFD1L UPF1 DDX55 NUBP2 GSPT1 ORC1 MYH15 DHX34 SMC1B | 1.51e-04 | 848 | 232 | 24 | IPR027417 |
| Domain | Clathrin_a-adaptin_app_Ig-like | 1.54e-04 | 2 | 232 | 2 | IPR013038 | |
| Domain | Clathrin_b-adaptin_app_Ig-like | 1.54e-04 | 2 | 232 | 2 | IPR013037 | |
| Domain | Clathrin_a-adaptin_app_sub_C | 1.54e-04 | 2 | 232 | 2 | IPR003164 | |
| Domain | - | 1.54e-04 | 2 | 232 | 2 | 2.60.40.1030 | |
| Domain | - | 1.54e-04 | 2 | 232 | 2 | 2.60.40.1150 | |
| Domain | AP2_complex_asu | 1.54e-04 | 2 | 232 | 2 | IPR017104 | |
| Domain | Alpha_adaptin_C | 1.54e-04 | 2 | 232 | 2 | PF02296 | |
| Domain | BTB | 1.79e-04 | 160 | 232 | 9 | PS50097 | |
| Domain | PROTEIN_KINASE_ATP | SPEG TSSK2 DSTYK TESK2 CAMK2A LCK ERN2 STK31 LATS1 EPHA2 MAST1 ROS1 STK40 MAPK8 MAPK9 HCK | 2.11e-04 | 459 | 232 | 16 | PS00107 |
| Domain | - | ATP6V1B1 ABCA4 RTEL1 RRAGC ABCB1 RRAGD NLRC5 DHX35 GNAS RAB39B SMARCA5 DDX17 LONP2 MTHFD1L UPF1 DDX55 NUBP2 GSPT1 ORC1 DHX34 SMC1B | 4.25e-04 | 746 | 232 | 21 | 3.40.50.300 |
| Domain | Prot_kinase_dom | SPEG TSSK2 DSTYK TESK2 CAMK2A LCK ERN2 STK31 LATS1 EPHA2 MAST1 ROS1 STK40 MAPK8 MAPK9 HCK | 4.25e-04 | 489 | 232 | 16 | IPR000719 |
| Domain | STPPase_N | 4.57e-04 | 3 | 232 | 2 | IPR031675 | |
| Domain | B2-adapt-app_C | 4.57e-04 | 3 | 232 | 2 | PF09066 | |
| Domain | AP_complex_bsu_1_2_4 | 4.57e-04 | 3 | 232 | 2 | IPR016342 | |
| Domain | STPPase_N | 4.57e-04 | 3 | 232 | 2 | PF16891 | |
| Domain | PROTEIN_KINASE_DOM | SPEG TSSK2 DSTYK TESK2 CAMK2A LCK ERN2 STK31 LATS1 EPHA2 MAST1 ROS1 STK40 MAPK8 MAPK9 HCK | 4.65e-04 | 493 | 232 | 16 | PS50011 |
| Domain | I-BAR_dom | 4.94e-04 | 13 | 232 | 3 | IPR013606 | |
| Domain | SKP1/BTB/POZ | 6.10e-04 | 189 | 232 | 9 | IPR011333 | |
| Domain | - | 6.35e-04 | 32 | 232 | 4 | 3.40.1110.10 | |
| Domain | - | 6.35e-04 | 32 | 232 | 4 | 2.70.150.10 | |
| Domain | LY | 7.71e-04 | 15 | 232 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 7.71e-04 | 15 | 232 | 3 | IPR000033 | |
| Domain | ATPase_P-typ_cyto_domN | 8.98e-04 | 35 | 232 | 4 | IPR023299 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 8.98e-04 | 35 | 232 | 4 | IPR002464 | |
| Domain | Gtr1_RagA | 9.07e-04 | 4 | 232 | 2 | IPR006762 | |
| Domain | DNA_pol_B | 9.07e-04 | 4 | 232 | 2 | PF00136 | |
| Domain | B2-adapt-app_C | 9.07e-04 | 4 | 232 | 2 | SM01020 | |
| Domain | DNA-dir_DNA_pol_B | 9.07e-04 | 4 | 232 | 2 | IPR006172 | |
| Domain | DNA-dir_DNA_pol_B_exonuc | 9.07e-04 | 4 | 232 | 2 | IPR006133 | |
| Domain | DNA-dir_DNA_pol_B_multi_dom | 9.07e-04 | 4 | 232 | 2 | IPR006134 | |
| Domain | Gtr1_RagA | 9.07e-04 | 4 | 232 | 2 | PF04670 | |
| Domain | B-adaptin_app_sub_C | 9.07e-04 | 4 | 232 | 2 | IPR015151 | |
| Domain | - | 9.07e-04 | 4 | 232 | 2 | 3.30.310.30 | |
| Domain | POLBc | 9.07e-04 | 4 | 232 | 2 | SM00486 | |
| Domain | Clathrin_a/coatomer_app_sub_C | 9.07e-04 | 4 | 232 | 2 | IPR015873 | |
| Domain | DNA_pol_B_exo1 | 9.07e-04 | 4 | 232 | 2 | PF03104 | |
| Domain | ATPase_P-typ_P_site | 1.00e-03 | 36 | 232 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 1.00e-03 | 36 | 232 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 1.00e-03 | 36 | 232 | 4 | PS00154 | |
| Domain | ATPase_P-typ_transduc_dom_A | 1.11e-03 | 37 | 232 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 1.11e-03 | 37 | 232 | 4 | PF00122 | |
| Domain | - | 1.19e-03 | 95 | 232 | 6 | 2.60.120.200 | |
| Domain | DEAH_ATP_HELICASE | 1.23e-03 | 38 | 232 | 4 | PS00690 | |
| Domain | Kinase-like_dom | SPEG TSSK2 DSTYK TESK2 CAMK2A LCK ERN2 STK31 LATS1 EPHA2 MAST1 ROS1 STK40 MAPK8 MAPK9 HCK | 1.27e-03 | 542 | 232 | 16 | IPR011009 |
| Domain | ARM | 1.49e-03 | 40 | 232 | 4 | SM00185 | |
| Domain | AP_beta | 1.50e-03 | 5 | 232 | 2 | IPR026739 | |
| Domain | MAPK_JNK | 1.50e-03 | 5 | 232 | 2 | IPR008351 | |
| Domain | DUF4704 | 1.50e-03 | 5 | 232 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.50e-03 | 5 | 232 | 2 | PF15787 | |
| Domain | Protocadherin | 1.50e-03 | 5 | 232 | 2 | PF08374 | |
| Domain | Protocadherin | 1.50e-03 | 5 | 232 | 2 | IPR013585 | |
| Domain | CBS | 1.84e-03 | 20 | 232 | 3 | PS51371 | |
| Domain | CBS_dom | 1.84e-03 | 20 | 232 | 3 | IPR000644 | |
| Domain | CBS | 1.84e-03 | 20 | 232 | 3 | PF00571 | |
| Domain | BTB | 1.89e-03 | 180 | 232 | 8 | SM00225 | |
| Domain | WD40_repeat | 2.20e-03 | 272 | 232 | 10 | IPR001680 | |
| Domain | PH_BEACH | 2.23e-03 | 6 | 232 | 2 | PF14844 | |
| Domain | - | 2.23e-03 | 6 | 232 | 2 | 3.30.310.10 | |
| Domain | Beta2_adaptin/TBP_C_dom | 2.23e-03 | 6 | 232 | 2 | IPR012295 | |
| Domain | BTB/POZ_dom | 2.24e-03 | 185 | 232 | 8 | IPR000210 | |
| Domain | - | 2.27e-03 | 74 | 232 | 5 | 3.40.50.410 | |
| Pathway | REACTOME_THE_ROLE_OF_NEF_IN_HIV_1_REPLICATION_AND_DISEASE_PATHOGENESIS | 8.22e-07 | 28 | 169 | 6 | M11362 | |
| Pathway | REACTOME_NEF_MEDIATED_CD4_DOWN_REGULATION | 2.40e-06 | 9 | 169 | 4 | M27011 | |
| Pathway | REACTOME_NEF_MEDIATES_DOWN_MODULATION_OF_CELL_SURFACE_RECEPTORS_BY_RECRUITING_THEM_TO_CLATHRIN_ADAPTERS | 4.07e-06 | 21 | 169 | 5 | M12347 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 2.20e-05 | 29 | 169 | 5 | MM15028 | |
| Pathway | REACTOME_HOST_INTERACTIONS_OF_HIV_FACTORS | 2.80e-05 | 131 | 169 | 9 | M5283 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 3.08e-05 | 31 | 169 | 5 | M7223 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 3.83e-05 | 170 | 169 | 10 | M27582 | |
| Pathway | REACTOME_NEF_MEDIATED_CD8_DOWN_REGULATION | 5.72e-05 | 7 | 169 | 3 | M27044 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | 6.56e-05 | 146 | 169 | 9 | MM15292 | |
| Pathway | WP_COMMON_PATHWAYS_UNDERLYING_DRUG_ADDICTION | 1.23e-04 | 41 | 169 | 5 | M39655 | |
| Pathway | WP_MISMATCH_REPAIR | 1.35e-04 | 9 | 169 | 3 | MM15932 | |
| Pathway | WP_DNA_MISMATCH_REPAIR | 1.48e-04 | 23 | 169 | 4 | M39668 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V1B1 TRPC4AP ABCA4 ATP9B ATP8B1 ABCB1 PSMD6 TRPM5 CLCN2 CLCN4 AP2A1 AP2A2 AP2B1 SLC27A1 GNAS CAMK2A ESYT1 SLC1A7 SLC22A2 ATP2B2 | 1.91e-04 | 681 | 169 | 20 | MM14985 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | ATP6V1B1 TRPC4AP ABCA4 ATP9B ATP8B1 ABCB1 PSMD6 TRPM5 CLCN2 CLCN4 AP2A1 AP2A2 AP2B1 SLC27A1 GNAS SLC25A6 CAMK2A ESYT1 SLC1A7 SLC22A2 ATP2B2 | 1.95e-04 | 736 | 169 | 21 | M27287 |
| Pathway | REACTOME_NEURONAL_SYSTEM | MYO6 LRRTM3 AP2A1 AP2A2 AP2B1 PLCB2 SHANK1 CAMK2A GLRA3 GRIK4 GRM1 SLC1A7 SLC22A2 | 2.01e-04 | 335 | 169 | 13 | MM14503 |
| Pathway | REACTOME_TRANSMISSION_ACROSS_CHEMICAL_SYNAPSES | MYO6 AP2A1 AP2A2 AP2B1 PLCB2 CAMK2A GLRA3 GRIK4 SLC1A7 SLC22A2 | 2.31e-04 | 211 | 169 | 10 | MM14502 |
| Pathway | KEGG_MEDICUS_REFERENCE_MISMATCH_REPAIR | 2.43e-04 | 26 | 169 | 4 | M47827 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 2.60e-04 | 11 | 169 | 3 | MM14694 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP6V1B1 TRPC4AP ATP9B ATP8B1 TRPM5 CLCN2 CLCN4 CAMK2A ATP2B2 | 2.71e-04 | 176 | 169 | 9 | MM15718 |
| Pathway | REACTOME_NEUROTRANSMITTER_RECEPTORS_AND_POSTSYNAPTIC_SIGNAL_TRANSMISSION | 3.42e-04 | 144 | 169 | 8 | MM14501 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 3.44e-04 | 12 | 169 | 3 | MM15163 | |
| Pathway | REACTOME_ION_CHANNEL_TRANSPORT | ATP6V1B1 TRPC4AP ATP9B ATP8B1 TRPM5 CLCN2 CLCN4 CAMK2A ATP2B2 | 3.62e-04 | 183 | 169 | 9 | M997 |
| Pathway | WP_DNA_IRDAMAGE_AND_CELLULAR_RESPONSE_VIA_ATR | 4.19e-04 | 81 | 169 | 6 | M39490 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 4.28e-04 | 30 | 169 | 4 | M257 | |
| Pathway | REACTOME_CYTOSOLIC_IRON_SULFUR_CLUSTER_ASSEMBLY | 4.43e-04 | 13 | 169 | 3 | M27193 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD2_FZD5_AND_ROR2 | 4.43e-04 | 13 | 169 | 3 | M27415 | |
| Pathway | REACTOME_HIV_INFECTION | 4.74e-04 | 231 | 169 | 10 | M12469 | |
| Pathway | PID_WNT_NONCANONICAL_PATHWAY | 5.52e-04 | 32 | 169 | 4 | M23 | |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 5.59e-04 | 14 | 169 | 3 | MM15161 | |
| Pathway | REACTOME_RETROGRADE_NEUROTROPHIN_SIGNALLING | 5.59e-04 | 14 | 169 | 3 | M10122 | |
| Pathway | WP_FRAGILE_X_SYNDROME | 6.31e-04 | 121 | 169 | 7 | M39804 | |
| Pathway | REACTOME_CELL_CYCLE | RTEL1 CKAP5 NCAPG2 PSMD6 MLH1 HERC2 KPNB1 SMARCA5 RBBP8 RBL2 POLD1 POLE CEP192 ODF2 PPP1CB ESCO2 ORC1 EXO1 SMC1B | 6.62e-04 | 694 | 169 | 19 | M543 |
| Pathway | REACTOME_WNT5A_DEPENDENT_INTERNALIZATION_OF_FZD4 | 6.93e-04 | 15 | 169 | 3 | M27413 | |
| Pathway | REACTOME_MISMATCH_REPAIR | 6.93e-04 | 15 | 169 | 3 | M27442 | |
| Pathway | REACTOME_MISMATCH_REPAIR | 6.93e-04 | 15 | 169 | 3 | MM15184 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 8.45e-04 | 16 | 169 | 3 | M27761 | |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 8.45e-04 | 16 | 169 | 3 | MM15048 | |
| Pathway | REACTOME_VLDLR_INTERNALISATION_AND_DEGRADATION | 8.45e-04 | 16 | 169 | 3 | MM15506 | |
| Pathway | REACTOME_CELL_CYCLE | RTEL1 CKAP5 NCAPG2 PSMD6 HERC2 KPNB1 SMARCA5 RBBP8 RBL2 POLD1 POLE CEP192 ODF2 PPP1CB ESCO2 ORC1 EXO1 | 9.31e-04 | 603 | 169 | 17 | MM14635 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 CASP14 MYO6 AUP1 CKAP5 PFAS PFKM PGD NCAPG2 AP2A1 AP2A2 AP2B1 MKI67 MLH1 HERC2 NONO MVP KPNB1 SMARCA5 DNAJC13 DDX17 DSC3 TCP1 MTHFD1L ESYT1 POLD1 POLE OAS3 UPF1 XRCC5 GSPT1 PPP1CA PPP1CB ORC1 ARAP3 LLGL1 GTF3C1 BAZ1A GEMIN4 WDFY3 CTNND1 LYZ DHX34 | 4.28e-17 | 1353 | 239 | 43 | 29467282 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | MON2 TRPC4AP AUP1 CKAP5 PFAS HSPBP1 EYA3 PFKM PGD NCAPG2 CKB PSMD6 AP2A1 AP1B1 AP2B1 GNAS KPNB1 CARM1 TOR1AIP2 ARHGAP10 MTHFD1L ESYT1 POLD1 POLE RANBP6 CNNM3 ARAP3 GTF3C1 EPHA2 KCTD3 GEMIN4 MAPK8 MAPK9 | 4.86e-14 | 974 | 239 | 33 | 28675297 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EPRS1 MYO6 AUP1 CKAP5 PFAS HSPBP1 PFKM PGD CKB PSMD6 AP2A1 AP2A2 KCTD16 MKI67 GNAS MYO18B NONO KPNB1 SMARCA5 IRS4 DDX17 TCP1 MTHFD1L ESYT1 POLD1 POLE UPF1 GRM1 DDX55 XRCC5 GSPT1 PPP1CA GTF3C1 PELP1 BAZ1A SEC23IP GEMIN4 CTNND1 | 8.23e-13 | 1425 | 239 | 38 | 30948266 |
| Pubmed | EPRS1 MYO6 AUP1 CKAP5 NCAPG2 AP2A1 AP2B1 BST2 NBEAL2 SLC27A1 MKI67 MLH1 ATP13A3 GNAS HERC2 NONO MVP KPNB1 DNAJC13 DDX17 LONP2 MTHFD1L ESYT1 POLD1 DDX55 XRCC5 CNNM3 GTF3C1 PELP1 GEMIN4 STARD3NL DHX34 | 3.21e-11 | 1168 | 239 | 32 | 19946888 | |
| Pubmed | EPRS1 RGS11 PFKM PDE10A ABCB1 CLCN4 AP2A1 AP2A2 AP2B1 SLC27A1 SCN4A RAB39B NONO KPNB1 PLXNA3 SMARCA5 IRS4 DDX17 SLC25A6 RBBP8 ODF2 DDX55 XRCC5 STK31 GSPT1 PPP1CA PPP1CB LATS1 GTF3C1 BAZ1A SEC23IP MYH15 ZBTB11 ATP2B2 | 3.89e-10 | 1442 | 239 | 34 | 35575683 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MON2 TRPC4AP HSPBP1 NCAPG2 PSMD6 SETDB1 AP2A1 AP2A2 AP2B1 TESK2 MIOS IFT80 TARBP2 KPNB1 TOR1AIP2 DNAJC13 DDX17 LONP2 ARHGAP10 CAMK2A ESYT1 POLD1 HDAC7 PPP1CA PPP1CB SEC23IP KCTD3 ANKRD34A STARD3NL MUC5AC ATP2B2 PCDH9 | 6.99e-10 | 1321 | 239 | 32 | 27173435 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | MON2 EPRS1 MYO6 AUP1 PFAS PFKM NCAPG2 PSMD6 GNAS NONO KPNB1 CARM1 TOR1AIP2 IRS4 DDX17 SLC25A6 TCP1 MTHFD1L ESYT1 POLD1 POLE UPF1 XRCC5 NUBP2 GSPT1 PPP1CA PPP1CB GTF3C1 GEMIN4 EXO1 CTNND1 | 8.65e-10 | 1257 | 239 | 31 | 37317656 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MON2 SPEG PFAS ZZEF1 AP2A1 NBEAL2 NLRC5 HERC2 SEMA6B PLXNA3 MTHFD1L ESYT1 POLE ZBTB4 CEP192 HDAC7 RGS16 ORC1 NHSL1 ARAP3 ANKRD34A DIP2C LRP4 LRP5 WDFY3 STK40 SNAPC4 DHX34 | 3.38e-09 | 1105 | 239 | 28 | 35748872 |
| Pubmed | EPRS1 CKAP5 PSMD6 AP1B1 AP2B1 NONO KPNB1 CARM1 SMARCA5 DNAJC13 IRS4 DDX17 TCP1 ESYT1 POLD1 UPF1 XRCC5 GSPT1 PELP1 SEC23IP GEMIN4 | 4.18e-09 | 638 | 239 | 21 | 33239621 | |
| Pubmed | LukS-PV inhibits hepatocellular carcinoma cells migration by downregulating HDAC6 expression. | EPRS1 MYO6 PFKM PGD CKB PSMD6 AP2A1 AP2A2 AP2B1 BST2 GNAS NONO DDX17 SLC25A6 TCP1 OAS3 UPF1 PPP1CA EPHA2 CTNND1 | 4.56e-09 | 580 | 239 | 20 | 35676659 |
| Pubmed | EPRS1 CKB AP2A1 AP2A2 AP1B1 AP2B1 MLH1 NONO IRS4 DDX17 SLC25A6 TCP1 NUBP2 PPP1CA PPP1CB GTF3C1 PELP1 | 4.80e-09 | 411 | 239 | 17 | 36652389 | |
| Pubmed | CKAP5 PFAS CKB AP1B1 AP2B1 MKI67 HERC2 MVP KPNB1 SMARCA5 IRS4 MTHFD1L POLE UPF1 XRCC5 PPP1CA PPP1CB GTF3C1 PELP1 GEMIN4 ZBTB11 | 6.26e-09 | 653 | 239 | 21 | 22586326 | |
| Pubmed | MON2 AUP1 PFAS HSPBP1 PSMD6 COCH HERC2 TOR1AIP2 SMARCA5 DNAJC13 MTHFD1L POLD1 POLE RANBP6 NUBP2 PPP1CA PPP1CB VPS13D SEC23IP CTNND1 | 9.50e-09 | 606 | 239 | 20 | 36538041 | |
| Pubmed | EPRS1 CASP14 PFKM PGD CKB AP2A1 AP2B1 MKI67 GNAS NONO MVP KPNB1 SMARCA5 DNAJC13 DDX17 SLC25A6 TCP1 MTHFD1L ESYT1 UPF1 XRCC5 PPP1CB OXNAD1 | 1.01e-08 | 803 | 239 | 23 | 36517590 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EPRS1 CKAP5 PFAS HSPBP1 PFKM CKB AP2A1 AP2A2 AP1B1 AP2B1 NONO KPNB1 CARM1 SMARCA5 DDX17 SLC25A6 TCP1 LONP2 MTHFD1L POLD1 UPF1 DDX55 XRCC5 NUBP2 GSPT1 PPP1CA PPP1CB PELP1 GEMIN4 IAH1 CTNND1 | 1.38e-08 | 1415 | 239 | 31 | 28515276 |
| Pubmed | MON2 AUP1 PFKM NCAPG2 CKB PSMD6 AP2A2 AP2B1 BST2 MKI67 ATP13A3 GNAS NONO KPNB1 IRS4 SLC25A6 TCP1 MTHFD1L ESYT1 POLD1 RANBP6 OAS3 UPF1 XRCC5 GSPT1 PPP1CA GTF3C1 PELP1 GEMIN4 LRP4 LYZ | 2.05e-08 | 1440 | 239 | 31 | 30833792 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | REC114 AUP1 PSMD6 AP2A1 AP2A2 AP1B1 AP2B1 BST2 CPLANE1 CARM1 RCAN1 RBL2 CEP192 LCK PPP1CA PPP1CB LATS1 GTF3C1 EPHA2 MYH15 CTNND1 MAPK8 MAPK9 HCK | 2.28e-08 | 910 | 239 | 24 | 36736316 |
| Pubmed | EPRS1 MYO6 CKB AP2A1 RRAGD AP2A2 AP1B1 AP2B1 MKI67 GNAS HERC2 NONO TARBP2 SMARCA5 TCP1 ESYT1 OAS3 UPF1 DDX55 XRCC5 PPP1CB ESCO2 BAZ1A EPHA2 GEMIN4 ROS1 CTNND1 LYZ MUC5AC MBNL3 | 2.48e-08 | 1371 | 239 | 30 | 36244648 | |
| Pubmed | MON2 MYO6 HSPBP1 ZCCHC2 CKB AP1B1 MKI67 NONO IRS4 UPF1 BRMS1L PPP1CB GEMIN4 | 2.62e-08 | 253 | 239 | 13 | 29911972 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | CKAP5 PFKM AP1B1 MLH1 GNAS NONO MVP KPNB1 SMARCA5 DNAJC13 DDX17 TCP1 POLD1 POLE UPF1 GSPT1 PPP1CA GEMIN4 CTNND1 | 2.68e-08 | 582 | 239 | 19 | 20467437 |
| Pubmed | HSPBP1 PFKM PGD PM20D2 CKB PSMD6 SEC24D AP2A1 AP2B1 BST2 MKI67 MLH1 GNAS KPNB1 TOR1AIP2 DNAJC13 COL12A1 DDX17 SLC25A6 TCP1 MTHFD1L ESYT1 DDX55 XRCC5 PPP1CA PPP1CB PELP1 BAZ1A IAH1 | 2.73e-08 | 1297 | 239 | 29 | 33545068 | |
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 10966473 | ||
| Pubmed | 3.23e-08 | 6 | 239 | 4 | 20186153 | ||
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | MON2 MYO6 ZCCHC2 ABCB1 MIOS GNAS HERC2 POLD1 FMNL3 LLGL1 GTF3C1 EPHA2 GEMIN4 CTNND1 | 4.31e-08 | 313 | 239 | 14 | 38270169 |
| Pubmed | EPRS1 MYO6 PFAS PFKM AP2A1 AP2A2 AP2B1 MKI67 MLH1 DHX35 GNAS NONO MVP KPNB1 SMARCA5 DDX17 SLC25A6 TCP1 POLD1 UPF1 XRCC5 HDAC7 GSPT1 PPP1CA PPP1CB LATS1 EPHA2 CTNND1 | 4.42e-08 | 1247 | 239 | 28 | 27684187 | |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EPRS1 MYO6 FAM111B AP2A1 AP2A2 AP2B1 MKI67 DHX35 GNAS NONO MVP KPNB1 SMARCA5 DDX17 SLC25A6 TCP1 UPF1 DDX55 XRCC5 PPP1CA PPP1CB LLGL1 GEMIN4 LYZ | 4.99e-08 | 949 | 239 | 24 | 36574265 |
| Pubmed | TIF1γ inhibits lung adenocarcinoma EMT and metastasis by interacting with the TAF15/TBP complex. | CKAP5 PFAS IRS4 DDX17 MTHFD1L RBL2 ESYT1 UPF1 XRCC5 FCRL5 ZBTB11 | 5.15e-08 | 179 | 239 | 11 | 36261009 |
| Pubmed | EPRS1 MYO6 CKAP5 PFKM CKB PSMD6 NEFH AP2A1 AP2A2 AP1B1 AP2B1 SLC27A1 FGA MIOS KPNB1 SHANK1 DNAJC13 DDX17 TCP1 CAMK2A UPF1 GRM1 PPP1CA PPP1CB NHSL1 MAST1 CTNND1 LYZ ATP2B2 HCK | 6.34e-08 | 1431 | 239 | 30 | 37142655 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | EPRS1 MYO6 PFKM CKB NEFH AP2A1 AP2A2 AP1B1 AP2B1 GNAS RAB39B MVP KPNB1 TCP1 CAMK2A GSPT1 PPP1CA ATP2B2 HCK | 7.39e-08 | 621 | 239 | 19 | 22794259 |
| Pubmed | MON2 MYO6 CKAP5 PFKM AP2A1 AP2A2 AP1B1 AP2B1 DHX35 KPNB1 SMARCA5 IRS4 SLC25A6 MTHFD1L ESYT1 PELP1 BAZ1A SEC23IP | 7.95e-08 | 560 | 239 | 18 | 35241646 | |
| Pubmed | MON2 PFAS PSMD6 MKI67 MLH1 MIOS HERC2 KPNB1 TOR1AIP2 DNAJC13 IRS4 DSC3 RCAN1 TCP1 ARHGAP10 CEP192 ODF2 PPP1CA PPP1CB NHSL1 CNNM3 KCTD3 CTNND1 MAPK8 MAPK9 | 8.04e-08 | 1049 | 239 | 25 | 27880917 | |
| Pubmed | METTL3 protects METTL14 from STUB1-mediated degradation to maintain m6 A homeostasis. | CKAP5 HSPBP1 CKB PSMD6 AP2A1 AP2A2 GNAS WDR17 MTHFD1L RANBP6 GEMIN4 IAH1 | 8.06e-08 | 231 | 239 | 12 | 36597993 |
| Pubmed | EPRS1 CLSTN3 MYO6 CKAP5 GPR37L1 EYA3 BRWD3 NELL1 SETDB1 AP2A1 AP2B1 DHX35 HERC2 WDR17 MVP KPNB1 SHANK1 RCAN1 RBL2 CAMK2A ZBTB4 ZNF343 ODF2 SEC23IP LRP4 MAST1 WDFY3 ZBTB11 | 8.23e-08 | 1285 | 239 | 28 | 35914814 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | CASP14 AUP1 CKAP5 PFAS PFKM PGD RRAGC PSMD6 SETDB1 AP2A1 AP1B1 GNAS NONO MVP KPNB1 SMARCA5 DNAJC13 DDX17 DSC3 TCP1 MTHFD1L ESYT1 OAS3 UPF1 XRCC5 GSPT1 PELP1 ASAH1 EPHA2 | 8.35e-08 | 1367 | 239 | 29 | 32687490 |
| Pubmed | EPRS1 RTEL1 CKAP5 AP2A1 AP2A2 AP1B1 AP2B1 NONO SMARCA5 DDX17 ESYT1 XRCC5 PELP1 GEMIN4 | 1.19e-07 | 340 | 239 | 14 | 24332808 | |
| Pubmed | EPRS1 MYO6 AUP1 CKAP5 PSMD6 KPNB1 CARM1 DDX17 DSC3 TCP1 ESYT1 UPF1 XRCC5 JMJD1C LATS1 LLGL1 EPHA2 SEC23IP GEMIN4 CTNND1 | 1.20e-07 | 708 | 239 | 20 | 39231216 | |
| Pubmed | Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. | 1.49e-07 | 8 | 239 | 4 | 2014052 | |
| Pubmed | EPRS1 PFAS ZZEF1 NCAPG2 FAM111B AP1B1 DSTYK MLH1 METTL16 TCP1 LONP2 POLE DDX55 JMJD1C ARAP3 LLGL1 GTF3C1 ZBTB11 DHX34 | 1.49e-07 | 650 | 239 | 19 | 38777146 | |
| Pubmed | MYO6 AUP1 ZZEF1 SETDB1 SEC24D AP2A1 AP2A2 AP1B1 HERC2 KPNB1 RANBP6 PPP1CA PPP1CB FMNL3 PELP1 BAZ1A LRP5 ZBTB11 | 1.76e-07 | 591 | 239 | 18 | 15231748 | |
| Pubmed | AUP1 RRAGC ANKRD13C GNAS TOR1AIP2 IRS4 DSC3 TCP1 ESYT1 CNNM3 LLGL1 EPHA2 SEC23IP CTNND1 PLEKHO1 PCDH9 | 1.82e-07 | 467 | 239 | 16 | 30194290 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EPRS1 MYO6 CKAP5 AP2A1 AP2B1 MKI67 GNAS NONO MVP KPNB1 SMARCA5 DDX17 DSC3 SLC25A6 TCP1 ESYT1 OAS3 UPF1 DDX55 XRCC5 PPP1CA PPP1CB GTF3C1 PELP1 GEMIN4 CTNND1 LYZ | 1.90e-07 | 1257 | 239 | 27 | 36526897 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EPRS1 CASP14 CKAP5 ABCB1 CKB PSMD6 AP2A1 MKI67 GNAS HERC2 NONO KPNB1 SMARCA5 IRS4 DDX17 SLC25A6 TCP1 XRCC5 PPP1CA CNNM3 GTF3C1 PELP1 BAZ1A CTNND1 | 2.01e-07 | 1024 | 239 | 24 | 24711643 |
| Pubmed | EPRS1 MYO6 CKAP5 PFAS PFKM CKB AP2A1 AP1B1 AP2B1 GNAS IRS4 MTHFD1L POLD1 UPF1 XRCC5 GTF3C1 CTNND1 | 2.11e-07 | 534 | 239 | 17 | 35032548 | |
| Pubmed | MYO6 AUP1 HSPBP1 BRWD3 SETDB1 MIOS IFT80 RANBP6 PPP1CA PPP1CB ATP2B2 | 2.48e-07 | 209 | 239 | 11 | 26389662 | |
| Pubmed | CKAP5 NEFH AP2A1 AP2A2 AP1B1 AP2B1 KCTD16 MIOS HERC2 KPNB1 SHANK1 CARM1 DNAJC13 CAMK2A UPF1 GRM1 XRCC5 PPP1CA PPP1CB PELP1 SEC23IP WDFY3 CTNND1 | 2.64e-07 | 963 | 239 | 23 | 28671696 | |
| Pubmed | Nuclear import of histone deacetylase 5 by requisite nuclear localization signal phosphorylation. | EPRS1 CKB PSMD6 NONO KPNB1 IRS4 DDX17 SLC25A6 TCP1 UPF1 XRCC5 PPP1CA | 2.66e-07 | 258 | 239 | 12 | 21081666 |
| Pubmed | FBXO32 links ubiquitination to epigenetic reprograming of melanoma cells. | AUP1 CKAP5 HSPBP1 PFKM GNAS CARM1 TOR1AIP2 SMARCA5 MTHFD1L GTF3C1 CTNND1 | 2.86e-07 | 212 | 239 | 11 | 33462405 |
| Pubmed | EPRS1 ABCB1 CKB SEC24D GNAS NONO KPNB1 CARM1 IRS4 DDX17 SLC25A6 MTHFD1L ESYT1 UPF1 SEC23IP CTNND1 | 2.94e-07 | 484 | 239 | 16 | 31995728 | |
| Pubmed | JNK expression by macrophages promotes obesity-induced insulin resistance and inflammation. | 3.20e-07 | 3 | 239 | 3 | 23223452 | |
| Pubmed | Oppositional regulation of Noxa by JNK1 and JNK2 during apoptosis induced by proteasomal inhibitors. | 3.20e-07 | 3 | 239 | 3 | 23593480 | |
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 27052181 | ||
| Pubmed | 3.20e-07 | 3 | 239 | 3 | 26269175 | ||
| Pubmed | 3.36e-07 | 131 | 239 | 9 | 28634551 | ||
| Pubmed | Diverse functions of myosin VI elucidated by an isoform-specific α-helix domain. | 3.52e-07 | 22 | 239 | 5 | 26950368 | |
| Pubmed | PTENα and PTENβ promote carcinogenesis through WDR5 and H3K4 trimethylation. | EPRS1 HSPBP1 MKI67 KPNB1 SMARCA5 IRS4 TCP1 UPF1 XRCC5 PELP1 GEMIN4 | 3.60e-07 | 217 | 239 | 11 | 31685992 |
| Pubmed | 3.78e-07 | 97 | 239 | 8 | 22360420 | ||
| Pubmed | EPRS1 CKAP5 PFKM PGD PSMD6 AP2B1 MKI67 MVP KPNB1 CARM1 SMARCA5 DDX17 TCP1 UPF1 XRCC5 SEC23IP | 3.86e-07 | 494 | 239 | 16 | 26831064 | |
| Pubmed | 4.06e-07 | 67 | 239 | 7 | 29357390 | ||
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | EPRS1 MYO6 CKAP5 PFAS PGD CKB PSMD6 AP2A1 AP2A2 AP1B1 AP2B1 GNAS NONO KPNB1 IRS4 DDX17 TCP1 POLD1 UPF1 XRCC5 GSPT1 PPP1CA PPP1CB GTF3C1 GEMIN4 | 4.39e-07 | 1149 | 239 | 25 | 35446349 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | SETDB1 MKI67 MIOS DHX35 HERC2 SMARCA5 IRS4 ESYT1 UPF1 DDX55 XRCC5 GTF3C1 PELP1 CTNND1 ZBTB11 | 4.73e-07 | 440 | 239 | 15 | 34244565 |
| Pubmed | EPRS1 MYO6 PSMD6 HERC2 NONO KPNB1 IRS4 DDX17 SLC25A6 TCP1 LONP2 MTHFD1L UPF1 GEMIN4 | 5.03e-07 | 383 | 239 | 14 | 29331416 | |
| Pubmed | EPRS1 CKAP5 CKB MKI67 NONO KPNB1 IRS4 DDX17 SLC25A6 TCP1 CEP192 XRCC5 PPP1CB | 5.61e-07 | 330 | 239 | 13 | 32529326 | |
| Pubmed | EPRS1 CASP14 MYO6 HSPBP1 PFKM PGD CKB AP1B1 MKI67 CARM1 IRS4 DDX17 SLC25A6 TCP1 MTHFD1L UPF1 XRCC5 LYZ | 5.73e-07 | 641 | 239 | 18 | 36057605 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | EPRS1 CKAP5 PFKM SETDB1 NONO DDX17 TCP1 POLD1 UPF1 XRCC5 GTF3C1 PELP1 BAZ1A | 6.00e-07 | 332 | 239 | 13 | 32786267 |
| Pubmed | EPRS1 MYO6 CKB PSMD6 AP2A1 AP2A2 AP1B1 AP2B1 IFT80 GNAS NONO TARBP2 KPNB1 CARM1 SMARCA5 IRS4 DDX17 SLC25A6 TCP1 RBBP8 MTHFD1L RANBP6 UPF1 XRCC5 PPP1CA GTF3C1 CTNND1 | 6.11e-07 | 1335 | 239 | 27 | 29229926 | |
| Pubmed | PFKM NCAPG2 CKB AP1B1 AP2B1 MIOS NONO KPNB1 SMARCA5 IRS4 DDX17 MTHFD1L XRCC5 GSPT1 SEC23IP | 6.45e-07 | 451 | 239 | 15 | 36168627 | |
| Pubmed | Human immunodeficiency virus (HIV) type-1, HIV-2 and simian immunodeficiency virus Nef proteins. | 6.98e-07 | 25 | 239 | 5 | 20594957 | |
| Pubmed | 7.47e-07 | 106 | 239 | 8 | 19394292 | ||
| Pubmed | PSMD6 AP2A1 AP2B1 GNAS KPNB1 TCP1 RBL2 CAMK2A XRCC5 PPP1CA LLGL1 MAST1 STK40 MAPK8 | 8.67e-07 | 401 | 239 | 14 | 25852190 | |
| Pubmed | MYO6 RRAGC AP2A1 AP2A2 AP2B1 MKI67 GNAS NONO SMARCA5 DDX17 SLC25A6 UPF1 XRCC5 PPP1CA PPP1CB BAZ1A EPHA2 CTNND1 | 8.70e-07 | 660 | 239 | 18 | 32780723 | |
| Pubmed | MYO6 AP2A1 AP2A2 AP2B1 GNAS SMARCA5 IRS4 SLC25A6 TCP1 XRCC5 PPP1CB LYZ | 8.87e-07 | 289 | 239 | 12 | 37132043 | |
| Pubmed | PFKM PDE10A CKB NEFH AP2A1 AP2A2 AP1B1 AP2B1 KPNB1 TCP1 CAMK2A PPP1CA PPP1CB ATP2B2 | 9.19e-07 | 403 | 239 | 14 | 30562941 | |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | HSPBP1 AP2A1 MKI67 NLRC5 HERC2 KPNB1 SMARCA5 DDX17 SLC25A6 RANBP6 PPP1CA GTF3C1 PELP1 KMT5B BAZ1A ZBTB11 | 1.05e-06 | 533 | 239 | 16 | 30554943 |
| Pubmed | MMS19 assembles iron-sulfur proteins required for DNA metabolism and genomic integrity. | 1.05e-06 | 150 | 239 | 9 | 22678362 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 24606904 | ||
| Pubmed | Disruption of the murine Ap2β1 gene causes nonsyndromic cleft palate. | 1.28e-06 | 4 | 239 | 3 | 20500056 | |
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 7534311 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 19805137 | ||
| Pubmed | 1.28e-06 | 4 | 239 | 3 | 20525557 | ||
| Pubmed | 1.31e-06 | 154 | 239 | 9 | 36490346 | ||
| Pubmed | MON2 EPRS1 CASP14 GNAS HERC2 PMAIP1 KPNB1 TOR1AIP2 DDX17 SLC25A6 TCP1 XRCC5 GEMIN4 LYZ | 1.41e-06 | 418 | 239 | 14 | 35338135 | |
| Pubmed | 1.48e-06 | 13 | 239 | 4 | 9882340 | ||
| Pubmed | MYO6 AUP1 PFAS HSPBP1 PFKM PGD NCAPG2 PM20D2 COCH IFT80 GNAS HERC2 TARBP2 TOR1AIP2 DNAJC13 DSC3 SLC25A6 MTHFD1L ESYT1 POLD1 POLE CEP192 UPF1 XRCC5 CNNM3 LLGL1 EPHA2 CTNND1 | 1.51e-06 | 1487 | 239 | 28 | 33957083 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CKAP5 AP2A1 MKI67 MIOS HERC2 TARBP2 SMARCA5 DNAJC13 DDX17 SLC25A6 POLE UPF1 DDX55 XRCC5 GTF3C1 PELP1 BAZ1A EXO1 ZBTB11 | 1.53e-06 | 759 | 239 | 19 | 35915203 |
| Pubmed | O-GlcNAcylation of SPOP promotes carcinogenesis in hepatocellular carcinoma. | PFAS AP2B1 MLH1 GNAS OAS3 XRCC5 GSPT1 PPP1CA PPP1CB BAZ1A CTNND1 | 1.69e-06 | 254 | 239 | 11 | 36604567 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYO6 AUP1 PFKM ZZEF1 FBXL4 FAM111B CKB PSMD6 FGA DHX35 GNAS HERC2 TOR1AIP2 IRS4 SLC25A6 TCP1 MTHFD1L ESYT1 POLE RANBP6 UPF1 BRMS1L DDX55 XRCC5 NUBP2 VPS13D SEC23IP GEMIN4 | 1.70e-06 | 1496 | 239 | 28 | 32877691 |
| Pubmed | EPRS1 PHLDA2 MKI67 NONO MVP KPNB1 TOR1AIP2 SMARCA5 DNAJC13 DDX17 SLC25A6 UPF1 DDX55 XRCC5 PPP1CB GTF3C1 PELP1 BAZ1A GEMIN4 CTNND1 | 1.95e-06 | 847 | 239 | 20 | 35850772 | |
| Pubmed | 2.16e-06 | 31 | 239 | 5 | 12171929 | ||
| Pubmed | Large-scale identification of c-MYC-associated proteins using a combined TAP/MudPIT approach. | 2.26e-06 | 211 | 239 | 10 | 17314511 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | EPRS1 MYO6 CKAP5 PFAS PFKM CKB AP2B1 MKI67 MLH1 NONO KPNB1 SMARCA5 IRS4 DDX17 TCP1 ESYT1 UPF1 XRCC5 BAZ1A SEC23IP CTNND1 | 2.31e-06 | 934 | 239 | 21 | 33916271 |
| Pubmed | 2.80e-06 | 15 | 239 | 4 | 12393188 | ||
| Pubmed | PFKM AP2A1 AP2A2 AP1B1 AP2B1 GNAS KPNB1 IRS4 XRCC5 NUBP2 EPHA2 CTNND1 | 2.81e-06 | 323 | 239 | 12 | 24797263 | |
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | EPRS1 MYO6 PGD AP2A1 AP2A2 AP2B1 DDX17 SLC25A6 TCP1 MTHFD1L PPP1CB | 2.84e-06 | 268 | 239 | 11 | 33024031 |
| Pubmed | A BioID-Derived Proximity Interactome for SARS-CoV-2 Proteins. | ATP9B CKB ADRA1B AP1B1 FGA ATP13A3 HERC2 CEP192 UPF1 NUBP2 GSPT1 CNNM3 LLGL1 ASAH1 SEC23IP PTCD2 LRP4 CTNND1 | 2.90e-06 | 719 | 239 | 18 | 35337019 |
| Pubmed | Endocytic Adaptor Proteins in Health and Disease: Lessons from Model Organisms and Human Mutations. | 3.17e-06 | 5 | 239 | 3 | 31671891 | |
| Pubmed | Weak Molecular Interactions in Clathrin-Mediated Endocytosis. | 3.17e-06 | 5 | 239 | 3 | 29184887 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 16723738 | ||
| Pubmed | Interaction of HIV-1 Gag with the clathrin-associated adaptor AP-2. | 3.17e-06 | 5 | 239 | 3 | 16139856 | |
| Pubmed | 3.17e-06 | 5 | 239 | 3 | 17108326 | ||
| Pubmed | Activation of JNK signaling promotes all-trans-retinal-induced photoreceptor apoptosis in mice. | 3.17e-06 | 5 | 239 | 3 | 32265302 | |
| Interaction | MAX interactions | MBTD1 PSMD6 KPNB1 SMARCA5 POLD1 BRMS1L XRCC5 PPP1CA PPP1CB LATS1 PELP1 BAZ1A HSD17B14 SP7 | 1.29e-06 | 251 | 231 | 14 | int:MAX |
| Interaction | LAMTOR1 interactions | MON2 ATP6V1B1 MYO6 PFAS PFKM RRAGC CKB AP2A1 RRAGD AP2A2 AP1B1 AP2B1 ATP13A3 GNAS DNAJC13 IRS4 DSC3 CEP192 XRCC5 CNNM3 LLGL1 EPHA2 SEC23IP CTNND1 | 3.15e-06 | 722 | 231 | 24 | int:LAMTOR1 |
| Interaction | USP11 interactions | MYO6 EYA3 SETDB1 AP2A1 AP2A2 AP2B1 MKI67 GNAS NONO KPNB1 IRS4 DDX17 TCP1 LCK XRCC5 PPP1CA LLGL1 PELP1 LYZ SP7 | 4.36e-06 | 539 | 231 | 20 | int:USP11 |
| Interaction | GSK3B interactions | CASP14 PFAS AP1B1 AP2B1 MKI67 HERC2 NONO MVP PMAIP1 KPNB1 DNAJC13 RCAN1 TCP1 CEP192 PPP1CA PPP1CB NHSL1 VPS13D EPHA2 GEMIN4 CTNND1 LYZ DHX34 PLEKHO1 MUC5AC SP7 | 7.82e-06 | 868 | 231 | 26 | int:GSK3B |
| Interaction | TOP3B interactions | MON2 EPRS1 MYO6 RTEL1 SPEG PFAS ZZEF1 AP2A1 NBEAL2 NLRC5 GNAS HERC2 ADAMTSL4 SEMA6B PLXNA3 MTHFD1L ESYT1 POLE ZBTB4 CEP192 UPF1 XRCC5 HDAC7 RGS16 ORC1 NHSL1 ARAP3 PELP1 ANKRD34A DIP2C LRP4 LRP5 WDFY3 STK40 SNAPC4 DHX34 | 1.23e-05 | 1470 | 231 | 36 | int:TOP3B |
| Interaction | CLEC16A interactions | MON2 AUP1 PFAS HSPBP1 PSMD6 COCH RAB39B HERC2 TOR1AIP2 SMARCA5 DNAJC13 MTHFD1L POLD1 POLE RANBP6 NUBP2 PPP1CA PPP1CB VPS13D SEC23IP CTNND1 | 1.26e-05 | 629 | 231 | 21 | int:CLEC16A |
| Interaction | LGALS9 interactions | EPRS1 RRAGC ABCB1 CKB SEC24D ATP13A3 GNAS NONO KPNB1 CARM1 DNAJC13 IRS4 DDX17 SLC25A6 MTHFD1L ESYT1 UPF1 SEC23IP CTNND1 PCDH9 | 1.56e-05 | 588 | 231 | 20 | int:LGALS9 |
| Interaction | SNW1 interactions | CKAP5 HSPBP1 PFKM AP1B1 MKI67 MLH1 DHX35 NONO MVP NR0B2 KPNB1 SMARCA5 DNAJC13 TCP1 RBL2 POLD1 POLE UPF1 ODF2 GSPT1 PPP1CA PPP1CB GEMIN4 | 1.75e-05 | 747 | 231 | 23 | int:SNW1 |
| Interaction | CDC42 interactions | EPRS1 CASP14 MYO6 AUP1 PFKM PGD NCAPG2 AP2A2 MKI67 ATP13A3 GNAS HERC2 PMAIP1 TOR1AIP2 IRS4 DSC3 SLC25A6 ARHGAP10 ESYT1 LCK HDAC7 FMNL3 CNNM3 LLGL1 EPHA2 SEC23IP KCTD3 LRP5 ZNF420 CTNND1 MAPK8 MAPK9 LYZ | 2.06e-05 | 1323 | 231 | 33 | int:CDC42 |
| Interaction | CCDC8 interactions | EPRS1 CASP14 CKAP5 CKB MKI67 GNAS HERC2 NONO KPNB1 SMARCA5 IRS4 DDX17 SLC25A6 TCP1 LCK XRCC5 CNNM3 GTF3C1 BAZ1A EPHA2 CTNND1 | 2.34e-05 | 656 | 231 | 21 | int:CCDC8 |
| Interaction | ACE2 interactions | EPRS1 CASP14 MYO6 CKAP5 HSPBP1 PFKM PGD CKB AP2A1 AP2A2 AP1B1 MKI67 GNAS MVP KPNB1 SHANK1 CARM1 IRS4 DDX17 SLC25A6 TCP1 MTHFD1L UPF1 XRCC5 PPP1CB KCTD3 MAST1 LYZ DHX34 | 2.80e-05 | 1106 | 231 | 29 | int:ACE2 |
| Interaction | AGAP2 interactions | AP2A1 AP2A2 AP1B1 AP2B1 KCTD16 GNAS SHANK1 CAMK2A GRM1 PPP1CA PPP1CB | 3.23e-05 | 210 | 231 | 11 | int:AGAP2 |
| Interaction | SIPA1L1 interactions | MYO6 TSSK2 TESK2 MKI67 POLD1 ODF2 HDAC7 LATS1 KCTD3 ANKRD34A | 3.37e-05 | 174 | 231 | 10 | int:SIPA1L1 |
| Interaction | BRCA1 interactions | EPRS1 INPP1 CKAP5 PFKM PGD NCAPG2 PSMD6 AP2A1 AP2B1 MKI67 MLH1 HERC2 MVP KPNB1 CARM1 SMARCA5 DDX17 TCP1 RBBP8 RBL2 POLD1 POLE UPF1 LCK ODF2 XRCC5 PPP1CA PPP1CB SEC23IP EXO1 SP7 | 4.13e-05 | 1249 | 231 | 31 | int:BRCA1 |
| Interaction | C9orf72 interactions | MON2 EPRS1 MYO6 AUP1 PFAS PFKM NCAPG2 PSMD6 GNAS RAB39B NONO KPNB1 CARM1 TOR1AIP2 IRS4 DDX17 SLC25A6 TCP1 MTHFD1L ESYT1 POLD1 POLE UPF1 XRCC5 NUBP2 GSPT1 PPP1CA PPP1CB GTF3C1 GEMIN4 EXO1 CTNND1 | 4.76e-05 | 1319 | 231 | 32 | int:C9orf72 |
| Interaction | LAMP3 interactions | AUP1 NCAPG2 RRAGC ABCB1 AP1B1 DSTYK ATP13A3 RAB39B TOR1AIP2 IRS4 ESYT1 LLGL1 EPHA2 SEC23IP LRP4 CTNND1 MAPK8 | 4.88e-05 | 486 | 231 | 17 | int:LAMP3 |
| Interaction | SUMO2 interactions | EPRS1 CKAP5 PFKM PGD CKB SETDB1 MKI67 NONO GCNA DDX17 TCP1 POLD1 UPF1 XRCC5 GTF3C1 PELP1 BAZ1A SLC22A2 CTNND1 | 5.48e-05 | 591 | 231 | 19 | int:SUMO2 |
| Interaction | TOP1 interactions | CKAP5 PDE10A MKI67 HERC2 NONO TARBP2 SMARCA5 DDX17 RBL2 POLD1 POLE OAS3 DDX55 XRCC5 PPP1CA PPP1CB LLGL1 GTF3C1 BAZ1A GEMIN4 EXO1 | 5.52e-05 | 696 | 231 | 21 | int:TOP1 |
| Interaction | BIRC3 interactions | EPRS1 AUP1 CKAP5 PFAS HSPBP1 PFKM PGD CKB PSMD6 AP2A1 KCTD16 MKI67 GNAS NONO KPNB1 SMARCA5 IRS4 DDX17 TCP1 MTHFD1L ESYT1 POLD1 UPF1 XRCC5 GSPT1 PPP1CA GTF3C1 PELP1 BAZ1A SEC23IP GEMIN4 CTNND1 | 5.90e-05 | 1334 | 231 | 32 | int:BIRC3 |
| Interaction | KCNA3 interactions | EPRS1 MYO6 AUP1 CKAP5 PFKM CKB PSMD6 KPNB1 CARM1 IRS4 DDX17 DSC3 TCP1 ESYT1 UPF1 XRCC5 JMJD1C ORC1 LATS1 LLGL1 EPHA2 SEC23IP GEMIN4 CTNND1 | 6.73e-05 | 871 | 231 | 24 | int:KCNA3 |
| Interaction | RAB5A interactions | MON2 MYO6 AUP1 MTSS1 CKAP5 PFAS ATP13A3 HERC2 MVP PMAIP1 CARM1 TOR1AIP2 SMARCA5 IRS4 SLC25A6 ESYT1 GRIK4 LLGL1 EPHA2 SEC23IP CTNND1 | 6.75e-05 | 706 | 231 | 21 | int:RAB5A |
| Interaction | ASAH1 interactions | 7.37e-05 | 89 | 231 | 7 | int:ASAH1 | |
| Interaction | NPRL2 interactions | 7.81e-05 | 121 | 231 | 8 | int:NPRL2 | |
| Interaction | LAMP2 interactions | EPRS1 ATP6V1B1 MYO6 AUP1 RRAGC AP2A1 AP1B1 AP2B1 MIOS ATP13A3 RAB39B HERC2 DNAJC13 IRS4 ESYT1 NUBP2 LLGL1 EPHA2 CTNND1 | 8.14e-05 | 609 | 231 | 19 | int:LAMP2 |
| Interaction | EGLN3 interactions | MYO6 AUP1 CKAP5 PFAS HSPBP1 EYA3 PFKM NCAPG2 PSMD6 MIOS GNAS TARBP2 KPNB1 CARM1 IRS4 TCP1 MTHFD1L POLD1 POLE CEP192 JMJD1C NUBP2 GSPT1 PPP1CA NHSL1 LLGL1 GTF3C1 KCTD3 GEMIN4 EXO1 CTNND1 | 8.20e-05 | 1296 | 231 | 31 | int:EGLN3 |
| Interaction | METTL14 interactions | CASP14 CKAP5 HSPBP1 CKB PSMD6 AP2A1 AP2A2 GNAS WDR17 NONO DDX17 SLC25A6 TCP1 MTHFD1L RANBP6 XRCC5 GEMIN4 IAH1 | 8.27e-05 | 558 | 231 | 18 | int:METTL14 |
| Interaction | C9orf78 interactions | MON2 MYO6 CKAP5 PFKM AP2A1 AP2A2 AP1B1 AP2B1 DHX35 KPNB1 SMARCA5 IRS4 SLC25A6 MTHFD1L ESYT1 NUBP2 PELP1 BAZ1A SEC23IP | 1.03e-04 | 620 | 231 | 19 | int:C9orf78 |
| Interaction | OVOL2 interactions | 1.10e-04 | 127 | 231 | 8 | int:OVOL2 | |
| Interaction | MAP1LC3A interactions | EPRS1 PFAS AP2A1 AP2A2 AP2B1 MVP IRS4 DDX17 TCP1 PELP1 WDFY3 | 1.12e-04 | 241 | 231 | 11 | int:MAP1LC3A |
| Interaction | YWHAZ interactions | SPEG CKAP5 PFAS GCKR PFKM AP2B1 SYDE2 NBEAL2 TESK2 KCTD16 HERC2 IRS4 DSC3 CAMK2A ESYT1 CEP192 LCK HDAC7 PPP1CA NHSL1 VPS13D LATS1 KMT5B ANKRD34A EXO1 MAST1 WDFY3 CTNND1 MAPK8 LYZ ATP2B2 | 1.13e-04 | 1319 | 231 | 31 | int:YWHAZ |
| Interaction | SLX4 interactions | RTEL1 NCAPG2 CKB AP2A1 AP2A2 AP1B1 AP2B1 MKI67 MLH1 NONO KPNB1 IRS4 DDX17 TCP1 YY2 ZBTB9 ZBTB12 ODF2 | 1.13e-04 | 572 | 231 | 18 | int:SLX4 |
| Interaction | H3C1 interactions | EPRS1 MYO6 PHLDA2 ZZEF1 SETDB1 AP2B1 MKI67 DHX35 CARM1 SMARCA5 SLC25A6 ARHGAP10 CAMK2A ESYT1 BRMS1L XRCC5 JMJD1C PPP1CA PPP1CB ESCO2 GTF3C1 PELP1 BAZ1A MYH15 | 1.13e-04 | 901 | 231 | 24 | int:H3C1 |
| Interaction | PPP1R9B interactions | MYO6 CKAP5 PFKM PDE10A CKB NEFH AP2A1 AP2A2 AP1B1 AP2B1 SYDE2 KPNB1 TCP1 RBL2 CAMK2A UPF1 PPP1CA PPP1CB ATP2B2 | 1.17e-04 | 626 | 231 | 19 | int:PPP1R9B |
| Interaction | ARAF interactions | EPRS1 PSMD6 MLH1 GNAS HERC2 NONO KPNB1 IRS4 DDX17 SLC25A6 TCP1 XRCC5 EPHA2 GEMIN4 | 1.19e-04 | 376 | 231 | 14 | int:ARAF |
| Interaction | DEPDC5 interactions | 1.39e-04 | 69 | 231 | 6 | int:DEPDC5 | |
| Interaction | SIRT7 interactions | CKAP5 PFAS CKB AP1B1 AP2B1 MKI67 HERC2 MVP NR0B2 KPNB1 IRS4 MTHFD1L POLE UPF1 XRCC5 PPP1CA PPP1CB GTF3C1 PELP1 GEMIN4 ZBTB11 | 1.40e-04 | 744 | 231 | 21 | int:SIRT7 |
| Interaction | NR3C1 interactions | TRPC4AP ABCA4 MYO6 AUP1 AP1B1 LINC01549 WDR17 NONO NR0B2 ACSS3 KPNB1 TOR1AIP2 POLE YY2 ZBTB9 MUC16 LCK STK31 JMJD1C NUBP2 PELP1 SEC23IP ZNF420 WDFY3 MAPK8 | 1.45e-04 | 974 | 231 | 25 | int:NR3C1 |
| Interaction | HDAC5 interactions | EPRS1 CKB PSMD6 NONO KPNB1 IRS4 DDX17 SLC25A6 TCP1 CAMK2A UPF1 XRCC5 HDAC7 PPP1CA KCTD3 | 1.48e-04 | 432 | 231 | 15 | int:HDAC5 |
| Interaction | H3-3A interactions | EPRS1 CKAP5 EYA3 BRWD3 MKI67 MLH1 HERC2 CARM1 SMARCA5 CAMK2A ZBTB9 DDX55 XRCC5 JMJD1C PPP1CA PPP1CB GTF3C1 PELP1 BAZ1A SNAPC4 ZBTB11 | 1.54e-04 | 749 | 231 | 21 | int:H3-3A |
| Interaction | DOT1L interactions | EPRS1 CKAP5 MKI67 NONO MVP KPNB1 CARM1 TOR1AIP2 SMARCA5 DNAJC13 DDX17 SLC25A6 UPF1 DDX55 XRCC5 PPP1CB ORC1 GTF3C1 PELP1 BAZ1A GEMIN4 CTNND1 | 1.59e-04 | 807 | 231 | 22 | int:DOT1L |
| Interaction | CYLD interactions | EPRS1 CASP14 MYO6 AUP1 CKAP5 PSMD6 AP2B1 HERC2 NONO MVP DNAJC13 DDX17 DSC3 SLC25A6 TCP1 MTHFD1L CAMK2A CEP192 UPF1 LCK ODF2 XRCC5 LYZ | 1.71e-04 | 868 | 231 | 23 | int:CYLD |
| Interaction | CHD3 interactions | EPRS1 CASP14 SETDB1 MKI67 NONO KPNB1 SMARCA5 DDX17 SLC25A6 TRIM54 BRMS1L DDX55 XRCC5 PPP1CA PPP1CB PELP1 BAZ1A GEMIN4 LYZ HCK SP7 | 1.78e-04 | 757 | 231 | 21 | int:CHD3 |
| Interaction | B3GNT2 interactions | MON2 EPRS1 CASP14 CKAP5 GNAS HERC2 KPNB1 CARM1 TOR1AIP2 DDX17 SLC25A6 TCP1 XRCC5 BAZ1A SEC23IP GEMIN4 LYZ | 1.82e-04 | 542 | 231 | 17 | int:B3GNT2 |
| Interaction | SPOP interactions | PFAS AP2B1 MLH1 GNAS NONO KPNB1 OAS3 UPF1 XRCC5 GSPT1 PPP1CA PPP1CB LATS1 BAZ1A CTNND1 LYZ | 1.84e-04 | 491 | 231 | 16 | int:SPOP |
| Interaction | FZR1 interactions | EPRS1 CASP14 SPEG CKAP5 RGS11 HSPBP1 ABCB1 CKB PSMD6 AP2A2 GNAS NONO KPNB1 IRS4 DDX17 SLC25A6 RBBP8 CAMK2A UPF1 DDX55 XRCC5 PPP1CA PPP1CB GTF3C1 PELP1 EPHA2 MAPK8 ZBTB11 | 1.90e-04 | 1172 | 231 | 28 | int:FZR1 |
| Interaction | AGR2 interactions | EPRS1 ZZEF1 PGD PSMD6 AP2A1 AP2A2 AP1B1 AP2B1 MLH1 GNAS NONO KPNB1 IRS4 DDX17 TFAP2D SLC25A6 TCP1 ESYT1 UPF1 XRCC5 PPP1CA CNNM3 MUC5AC HCK | 1.94e-04 | 934 | 231 | 24 | int:AGR2 |
| Interaction | BMP2K interactions | 2.08e-04 | 105 | 231 | 7 | int:BMP2K | |
| Interaction | POLE3 interactions | 2.21e-04 | 106 | 231 | 7 | int:POLE3 | |
| Interaction | STIP1 interactions | EPRS1 TSSK2 CKAP5 EYA3 FBXL4 PSMD6 AP1B1 AP2B1 NONO KPNB1 CARM1 SMARCA5 DNAJC13 IRS4 DDX17 TCP1 ESYT1 POLD1 UPF1 LCK XRCC5 GSPT1 PELP1 SEC23IP GEMIN4 | 2.37e-04 | 1006 | 231 | 25 | int:STIP1 |
| Interaction | HTT interactions | EPRS1 MYO6 MTSS1 PFKM CKB PSMD6 NEFH AP2A1 AP2A2 AP1B1 AP2B1 GNAS RAB39B MVP KPNB1 CARM1 TCP1 CAMK2A GRM1 GSPT1 PPP1CA LLGL1 ATP2B2 HCK | 2.46e-04 | 949 | 231 | 24 | int:HTT |
| Interaction | TRIM33 interactions | CKAP5 PFAS RRAGC FGA IRS4 DDX17 MTHFD1L RBL2 ESYT1 UPF1 XRCC5 GSPT1 FCRL5 ZBTB11 SP7 | 2.46e-04 | 453 | 231 | 15 | int:TRIM33 |
| Coexpression | GSE12845_NAIVE_VS_DARKZONE_GC_TONSIL_BCELL_UP | CLCN4 METTL16 ESYT1 PCDH11Y VPS13D KMT5B ROS1 WDFY3 CTNND1 HCK | 1.44e-05 | 198 | 238 | 10 | M3200 |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 1.57e-05 | 200 | 238 | 10 | M8403 | |
| Coexpression | GSE33424_CD161_INT_VS_NEG_CD8_TCELL_UP | INPP1 ZCCHC2 PGD ABCB1 NLRC5 TOR1AIP2 DNAJC13 OAS3 BAZ1A HCK | 1.57e-05 | 200 | 238 | 10 | M8554 |
| Coexpression | GSE40274_CTRL_VS_FOXP3_AND_XBP1_TRANSDUCED_ACTIVATED_CD4_TCELL_UP | 2.33e-05 | 167 | 238 | 9 | M9116 | |
| ToppCell | PBMC-Mild-cDC_12|Mild / Compartment, Disease Groups and Clusters | NCAPG2 FAM111B CLCN4 KCTD16 MKI67 KPNB1 NPTX2 POLE OAS3 ORC1 EXO1 | 6.45e-09 | 189 | 238 | 11 | 946c95d2ecc36b241f58e8c4ad6455fe47c762fa |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | REC114 PFKM NCAPG2 CLCN2 MKI67 SH3TC2 MFSD2B PKHD1L1 ESCO2 ORC1 | 7.07e-08 | 187 | 238 | 10 | dceca7ae3dae96078cccc17a0d8a61b06fa6dffb |
| ToppCell | droplet-Spleen-nan-3m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.17e-07 | 188 | 238 | 9 | 1a3f95b4fd7611c634666761ddf21f1e58e56af8 | |
| ToppCell | wk_08-11-Epithelial-Airway_epithelial_progenitor-epi-stalk_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 8.92e-07 | 190 | 238 | 9 | 9f5f65869dad9a43ac94f81f9a19c72ffe5adc3c | |
| ToppCell | droplet-Thymus-nan-18m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 198 | 238 | 9 | c78ff8fc71dfcba1ac0c373bc90ea7b87c5699a4 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.66e-06 | 169 | 238 | 8 | 121768fc51fc3441ec725346a1bbe29e21d05971 | |
| ToppCell | Ionocyte-iono-1|World / Class top | 3.66e-06 | 169 | 238 | 8 | 4b68bcb4b5fc3cd2db23cd4edace7444aa2d605c | |
| ToppCell | HSPCs-Erythroblasts|World / Lineage and Cell class | 6.07e-06 | 181 | 238 | 8 | ce26f1accc8f69b7bc4b929073e975c887566c6a | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.32e-06 | 182 | 238 | 8 | d486b0213bd3cf20965cb4e38e95981c4aaff259 | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo|blood / Manually curated celltypes from each tissue | 7.12e-06 | 185 | 238 | 8 | df85ff34b796b403f2d0741771e9592e03657f6a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 186 | 238 | 8 | 337f768cc43db2db96ba6495b076006b1a5b0331 | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 186 | 238 | 8 | e378c82ef6d6cb24751515aa499a01372b3e7ccf | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 186 | 238 | 8 | 7cdcf507a9a1349ed2cf62b79116367c3fc732dd | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.41e-06 | 186 | 238 | 8 | ac6e32cf07f0f013101ca7aedae0c562857f182b | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4/8-lo-Cycling_T|blood / Manually curated celltypes from each tissue | 8.01e-06 | 188 | 238 | 8 | 714ccbcf826f26d39757931a3b8abbd952f4cddc | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.99e-06 | 191 | 238 | 8 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-cycling_stromal|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.99e-06 | 191 | 238 | 8 | 50854384fdaa0efa2e3227659d544ed09ac102f2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.99e-06 | 191 | 238 | 8 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.99e-06 | 191 | 238 | 8 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | normal-na-Lymphocytic_B-B_naive-female|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.70e-06 | 193 | 238 | 8 | dd199163fc13f3d411fe741cf003237064349e22 | |
| ToppCell | normal-na-Lymphocytic_B-B_naive|normal / PBMC cell types (v2) per disease, treatment status, and sex | 9.70e-06 | 193 | 238 | 8 | 98279a3c69f1df062c4a8333e46c8fd649bf86b1 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 9.70e-06 | 193 | 238 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | AT1-AT2_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-05 | 140 | 238 | 7 | 45d52a086ced8d58e01ac51ac4a90338e8649b16 | |
| ToppCell | wk_20-22-Epithelial-Distal_epithelial-type_I_pneumocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.08e-05 | 196 | 238 | 8 | e24a7aaf41793abba66c1189d933ca05b14c1af9 | |
| ToppCell | (0)_NK_cells-(0)_NK_Dividing|(0)_NK_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.17e-05 | 198 | 238 | 8 | d9cdbc7d420472cb1ffb36ad9c8e53a61b7dbdeb | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal-Dividing_Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.17e-05 | 198 | 238 | 8 | d5e125f0c4f41b47d567568d0838adcca7655f6d | |
| ToppCell | (0)_NK_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.17e-05 | 198 | 238 | 8 | 5ebb4965b723302152b42bfaf48bb77a57dd02c5 | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 238 | 8 | da6963184c32761c896a9b91a5321ad84b583736 | |
| ToppCell | medial-2-Hematologic-Proliferating_Macrophage|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 238 | 8 | 64a2bcf5a9ba66a4fe08fbde33f1886c136cde8f | |
| ToppCell | medial-Hematologic-Proliferating_Macrophage-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.17e-05 | 198 | 238 | 8 | fcc14ac3eb5088b9d6cd6af5a34dee5b81c0ece8 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-Proliferating_Epithelial_cells|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.21e-05 | 199 | 238 | 8 | 4fcf5bec207e4384fd73c5e8801a7e414e3ee7b0 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar-Dividing_AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.21e-05 | 199 | 238 | 8 | 1d5a3366474c17e3df0ba5cf11b586655529e9bd | |
| ToppCell | mild-Non-classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.26e-05 | 200 | 238 | 8 | 334bab6bf93d455f3526e817ea5785d8b6ee531c | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-05 | 200 | 238 | 8 | b0e5c8b425f47833cdc00b5aa3734c8c980f0967 | |
| ToppCell | severe-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.26e-05 | 200 | 238 | 8 | 0e86f52b6e146d9bbc728d8fb176fc2b53696558 | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.26e-05 | 200 | 238 | 8 | f47bb79202a59404e4916993a1f59cffcf710320 | |
| ToppCell | COVID-19-Heart-CM_5_(RYR2-)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.26e-05 | 144 | 238 | 7 | f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.12e-05 | 156 | 238 | 7 | b3f10cd044f24807576e7d56e51df7064dbf6c50 | |
| ToppCell | 3'_v3-blood-Lymphocytic_Invariant-Inducer-like-ILC3|blood / Manually curated celltypes from each tissue | 2.21e-05 | 157 | 238 | 7 | eb2520c237543ea4869d4386afc0457b111f6193 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 160 | 238 | 7 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 160 | 238 | 7 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 2.81e-05 | 163 | 238 | 7 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 164 | 238 | 7 | 7dbe34a98a3b475c1ba678db8a5494c0c6a91e2d | |
| ToppCell | droplet-Fat-Gat-18m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.92e-05 | 164 | 238 | 7 | febcb8f8b305aa94e21131fa83d2890f7a6838fc | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-Tuft-related-Tuft|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.03e-05 | 165 | 238 | 7 | 34fd00be2b28716c871ad9fb356de84a299a0c01 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-SPN_Neuron_STR|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 165 | 238 | 7 | 1b7dfa173e83aa8c46a3153a3261866c065c3b73 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-medium_spiny_neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-05 | 165 | 238 | 7 | b4f7d33af7d053ec07b01bd67d861600a9c4822e | |
| ToppCell | Dividing_Macrophages-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 3.15e-05 | 166 | 238 | 7 | c503036f3c19ef186e1e62c9643c49dea3827f51 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.28e-05 | 167 | 238 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-05 | 170 | 238 | 7 | badbe200e9d5003d23d115955b10b4ea767f6c26 | |
| ToppCell | TCGA-Cervix|World / Sample_Type by Project: Shred V9 | 3.67e-05 | 170 | 238 | 7 | a6cbe253bc60f5d5cb361c7e85ed9928a3155ec8 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-GC_B_(I)|bone_marrow / Manually curated celltypes from each tissue | 4.10e-05 | 173 | 238 | 7 | 67f0f0bf88eab69987b71d96b864ed2b14975adb | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.10e-05 | 173 | 238 | 7 | 7c5e4809205ce1a0a301c15442af00a2e2b9b301 | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-05 | 174 | 238 | 7 | d5c22b43531414951666ee7542a66ed9380e2d14 | |
| ToppCell | Control-CD4+_T_activated|Control / Disease group and Cell class | 4.26e-05 | 174 | 238 | 7 | 2b683e81b315ad22555314433aed5681feb48da8 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-05 | 174 | 238 | 7 | 84da9faff088d05233183b425385beb054c92d1b | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_1|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.41e-05 | 175 | 238 | 7 | 6b4e841bde6cfa4956e1a0231672cea20f11210c | |
| ToppCell | Dividing_Macrophages-IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 4.91e-05 | 178 | 238 | 7 | 1893fadac2ec3d5de0a641e57b7b2f962012a9ba | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6-Exc_L5-6_THEMIS_TMEM233|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.09e-05 | 179 | 238 | 7 | 747a32460b257fffca30527b56a74720eb9c12e4 | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 179 | 238 | 7 | a634ca46ffc394c5f5215fc5d8eae4a77819af9c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.09e-05 | 179 | 238 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | BAL-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.09e-05 | 179 | 238 | 7 | 35f014b6e752626909d829c5ab9bb761c1f3e3dc | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.27e-05 | 180 | 238 | 7 | 5391d23817f5cc88a0871ddb98968897c839f464 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B|Lung / Manually curated celltypes from each tissue | 5.27e-05 | 180 | 238 | 7 | 237a2130a3f48595dad2417539c21e44585962b8 | |
| ToppCell | IIH-plasma|IIH / Condition, Cell_class and T cell subcluster | 5.46e-05 | 181 | 238 | 7 | 13d1f31bcbac21aea91de74f51eed549ec61003e | |
| ToppCell | IIH-plasma-|IIH / Condition, Cell_class and T cell subcluster | 5.46e-05 | 181 | 238 | 7 | 140ac43dc6b89396872f908c14c89278f6d982b2 | |
| ToppCell | PBMC-Control-cDC_12|Control / Compartment, Disease Groups and Clusters | 5.66e-05 | 182 | 238 | 7 | 4774066d0f9986abc3d13a2a3bc99ce4f1327ae0 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-myofibroblast_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 5.66e-05 | 182 | 238 | 7 | ed6ae0fd8653f213fe29906a6a4e0729a62e1b75 | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.66e-05 | 182 | 238 | 7 | 57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.75e-05 | 77 | 238 | 5 | 4a0a2f1a021790ff598a8655811eac1c367316b3 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)-Cplx3-Inhibitory_Neuron.Gad1Gad2.Cplx3-Dpy19l1_(Neuron.Gad1Gad2.Cplx3-Dpy19l1)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.75e-05 | 77 | 238 | 5 | 459fe29a53b88af77a4ced7b11fa1d0a17fec8e5 | |
| ToppCell | Control-T/NK-proliferating_T/NK|Control / Disease group,lineage and cell class (2021.01.30) | 5.85e-05 | 183 | 238 | 7 | e740f05536d1e4b2512811771928eb65f6696409 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 184 | 238 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 184 | 238 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.06e-05 | 184 | 238 | 7 | bc0dfe29337f02594e7e0092c9e47dda94b45ad5 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 184 | 238 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.06e-05 | 184 | 238 | 7 | 7d9bcdaff8cbea4c50ab7db0f8e01f6bbd0ef593 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l33-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.27e-05 | 185 | 238 | 7 | 47c69500877b851c0c9744f5e1ef2ee0bff99168 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 185 | 238 | 7 | a2cae8c657e4f4d121476798e424876f7e247973 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.27e-05 | 185 | 238 | 7 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | IIF-Lymphocyte-B-B_naive|IIF / Disease, Lineage and Cell Type | 6.27e-05 | 185 | 238 | 7 | dec48908addfc71f32f5ce0ce73f2926e476f60b | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-DN4_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.27e-05 | 185 | 238 | 7 | d50406a9a5b8d75110ba5985741aa2293950c543 | |
| ToppCell | droplet-Marrow-nan-21m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.48e-05 | 186 | 238 | 7 | 6e6998f5ccb1b2628048a21e8d3053e020569aba | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.71e-05 | 187 | 238 | 7 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 6.71e-05 | 187 | 238 | 7 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Chodl_(MGE-derived_cortical_interneurons--Long-range-projecting_interneurons)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.91e-05 | 80 | 238 | 5 | f102890f86fffb30d180a2450b71581181c803cf | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Sst-Inhibitory_Neuron.Gad1Gad2.Sst-Chodl_(MGE-derived_cortical_interneurons--Long-range-projecting_interneurons)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 6.91e-05 | 80 | 238 | 5 | 1f022bd04de842ec7193e98acae0df17913f4749 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-Cycling_NK|Liver / Manually curated celltypes from each tissue | 6.94e-05 | 188 | 238 | 7 | 5eb94e652a734c6f15c68a178e9d05f0febcf34c | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.94e-05 | 188 | 238 | 7 | f1a9d8ea174a4bef0fae8188e3bd96b7ac1a39bb | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 6.94e-05 | 188 | 238 | 7 | f5102e8d95506c25c675094b86162a6a50087b64 | |
| ToppCell | HSPCs-Ery_prog.|HSPCs / Lineage and Cell class | 7.17e-05 | 189 | 238 | 7 | 37d2c45debed1564a40a1085b8b310c50923b9e7 | |
| ToppCell | droplet-Marrow-nan-24m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.17e-05 | 189 | 238 | 7 | 98ace332c3c046694c6ade47de8c8bf57ec51271 | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.17e-05 | 189 | 238 | 7 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.17e-05 | 189 | 238 | 7 | 28b9e96a5206b7fdae9b17daf05c8f5d24b6c5ec | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.41e-05 | 131 | 238 | 6 | a3a086ce6e69707ca6a042f3b15c130f81909acb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 190 | 238 | 7 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Fetal_29-31_weeks-Immune-T_lymphocyte-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.41e-05 | 190 | 238 | 7 | 2a8de1cf27a9ebc3825cf9e7a489ecd064dfc7f9 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.66e-05 | 191 | 238 | 7 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | droplet-Spleen-SPLEEN-30m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 191 | 238 | 7 | c8b99bd3a30c81ee4deba9cbf0196920ab3ab550 | |
| ToppCell | droplet-Marrow-BM-1m-Hematologic-erythroblast|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.66e-05 | 191 | 238 | 7 | d78d4fbb0b8317dbf14e32182466a432abef3e93 | |
| Drug | Cefalonium [5575-21-3]; Up 200; 8.8uM; HL60; HT_HG-U133A | ZZEF1 CLCN4 FGA MVP PLXNA3 IRS4 OAS3 HDAC7 GSPT1 LLGL1 MAPK8 DHX34 ATP2B2 GSG1 | 2.03e-08 | 199 | 234 | 14 | 2921_UP |
| Drug | tempol | EPRS1 PFAS AP1B1 AP2B1 MLH1 CARM1 RBBP8 GRIK4 GRM1 XRCC5 MAPK8 MAPK9 | 3.31e-06 | 221 | 234 | 12 | CID000137994 |
| Drug | dicentrine | 3.39e-06 | 11 | 234 | 4 | CID000101300 | |
| Drug | CPG-oligonucleotide | RTEL1 EYA3 MLH1 NONO POLD1 POLE XRCC5 ESCO2 EXO1 MAPK8 MAPK9 | 3.40e-06 | 184 | 234 | 11 | ctd:C408982 |
| Drug | Minaprine dihydrochloride [25953-17-7]; Down 200; 10.8uM; HL60; HG-U133A | NEFH PLCB2 PMM1 SMARCA5 RCAN1 PPP1CB VPS13D ASAH1 SEC23IP GEMIN4 DHX34 | 5.94e-06 | 195 | 234 | 11 | 1968_DN |
| Drug | Nitrocaramiphen hydrochloride; Up 200; 10.8uM; MCF7; HT_HG-U133A | CAPN9 ATP6V1B1 MTSS1 RGS11 ZZEF1 DSTYK FGA GNAS RCAN1 CAMK2A DHX34 | 6.23e-06 | 196 | 234 | 11 | 6504_UP |
| Drug | Oleandomycin phosphate [7060-74-4]; Up 200; 5uM; MCF7; HT_HG-U133A | CAPN9 ADRA1B CLIC5 RRAGD NBEAL2 IRS4 LONP2 GRM1 HDAC7 VPS13D MBNL3 | 6.87e-06 | 198 | 234 | 11 | 1518_UP |
| Drug | dasatinib | 7.66e-06 | 70 | 234 | 7 | CID003062316 | |
| Drug | KU55933 | 9.45e-06 | 48 | 234 | 6 | CID005278396 | |
| Drug | Haloperidol | PDE10A ABCB1 AP2A2 AP2B1 GNAS NR0B2 NPTX2 CAMK2A GRIK4 GRM1 PPP1CB SLC22A2 MAPK8 MAPK9 | 1.33e-05 | 342 | 234 | 14 | ctd:D006220 |
| Drug | Demecolcine | KLHL24 INPP1 PFAS RRAGC FBXL4 ABCB1 FAM111B PM20D2 MIOS MVP PMAIP1 GCNA DDX17 RBBP8 POLE BRMS1L JMJD1C RGS16 GSPT1 ESCO2 ORC1 VPS13D GEMIN4 EXO1 | 1.37e-05 | 878 | 234 | 24 | ctd:D003703 |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; PC3; HT_HG-U133A | KLHL24 MYO6 ATP9B PMAIP1 TOR1AIP2 DDX17 UPF1 SNAPC4 PCDH9 PUS7L | 3.43e-05 | 194 | 234 | 10 | 4272_DN |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 3.74e-05 | 196 | 234 | 10 | 5015_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A | ATP9B PHLDA2 SEC24D PMAIP1 SMARCA5 RBL2 RGS16 PPP1CB VPS13D ASAH1 | 3.74e-05 | 196 | 234 | 10 | 1586_UP |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; HL60; HG-U133A | EPRS1 ATP9B ZZEF1 NCAPG2 SEC24D ATP13A3 PMAIP1 RBL2 PPP1CB MAPK9 | 3.91e-05 | 197 | 234 | 10 | 1386_DN |
| Drug | Orlistat; Down 200; 10uM; PC3; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 6388_DN | |
| Drug | magnesium | ATP6V1B1 CPAMD8 INPP1 PFKM PDE10A ABCB1 CKB TRPM5 AP2B1 FGA MLH1 PLCB2 PMM1 KPNB1 SLC25A6 MTHFD1L RBL2 POLD1 AMDHD1 GRIK4 UPF1 ODC1 LCK GRM1 ERN2 CNNM3 HSD17B14 ATP2B2 HCK SMC1B | 4.15e-05 | 1325 | 234 | 30 | CID000000888 |
| Drug | Folic acid [59-30-3]; Down 200; 9uM; PC3; HT_HG-U133A | KLHL24 AP2A2 AP2B1 DSTYK DHX35 RCAN1 SLC35G2 ERN2 VPS13D PTCD2 | 4.26e-05 | 199 | 234 | 10 | 5844_DN |
| Drug | rapamycin; Up 200; 0.1uM; MCF7; HG-U133A | KLHL24 CEACAM21 TESK2 ATP13A3 TOR1AIP2 RBL2 PPP1CB VPS13D CTNND1 SNAPC4 | 4.26e-05 | 199 | 234 | 10 | 326_UP |
| Drug | Trimetazidine dihydrochloride [13171-25-0]; Down 200; 11.8uM; HL60; HG-U133A | MBTD1 ZCCHC2 SEC24D AP2B1 VPS13D GTF3C1 KCTD3 GEMIN4 SNAPC4 LYZ | 4.26e-05 | 199 | 234 | 10 | 1727_DN |
| Drug | Calycanthine [595-05-1]; Up 200; 11.6uM; HL60; HG-U133A | RTEL1 GCKR CLIC5 AP2A2 AP2B1 ADAMTSL4 PPP1CB GEMIN4 DIP2C MAPK9 | 4.26e-05 | 199 | 234 | 10 | 1771_UP |
| Disease | Colorectal Carcinoma | CPAMD8 CLSTN3 ABCA4 ABCB1 NELL1 MKI67 MLH1 GNAS SHANK1 IRS4 MTHFD1L POLD1 POLE ODC1 GRM1 SLC1A7 ARAP3 EXO1 DIP2C | 3.37e-06 | 702 | 232 | 19 | C0009402 |
| Disease | colorectal cancer (implicated_via_orthology) | 3.49e-06 | 30 | 232 | 5 | DOID:9256 (implicated_via_orthology) | |
| Disease | follicular lymphoma (implicated_via_orthology) | 4.74e-06 | 5 | 232 | 3 | DOID:0050873 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | ACAP3 DDX17 RBL2 POLE RANBP6 LCK PPP1CA PPP1CB LATS1 LLGL1 HCK | 9.96e-06 | 268 | 232 | 11 | DOID:162 (implicated_via_orthology) |
| Disease | Neoplasms, Glandular and Epithelial | 6.16e-05 | 2 | 232 | 2 | C0027660 | |
| Disease | human immunodeficiency virus infectious disease (implicated_via_orthology) | 6.16e-05 | 2 | 232 | 2 | DOID:526 (implicated_via_orthology) | |
| Disease | Epithelioma | 6.16e-05 | 2 | 232 | 2 | C1368683 | |
| Disease | Glandular Neoplasms | 6.16e-05 | 2 | 232 | 2 | C0205854 | |
| Disease | kidney cancer (implicated_via_orthology) | 7.56e-05 | 11 | 232 | 3 | DOID:263 (implicated_via_orthology) | |
| Disease | cholesteryl esters to total lipids in large LDL percentage | 9.92e-05 | 31 | 232 | 4 | EFO_0022249 | |
| Disease | keratoconjunctivitis (is_marker_for) | 1.84e-04 | 3 | 232 | 2 | DOID:9368 (is_marker_for) | |
| Disease | gallstones | 2.17e-04 | 108 | 232 | 6 | EFO_0004210 | |
| Disease | lung cancer (is_implicated_in) | 2.98e-04 | 74 | 232 | 5 | DOID:1324 (is_implicated_in) | |
| Disease | AMYLOIDOSIS, FAMILIAL VISCERAL | 3.66e-04 | 4 | 232 | 2 | 105200 | |
| Disease | Familial visceral amyloidosis, Ostertag type | 3.66e-04 | 4 | 232 | 2 | cv:C0268389 | |
| Disease | familial visceral amyloidosis (is_implicated_in) | 3.66e-04 | 4 | 232 | 2 | DOID:0050636 (is_implicated_in) | |
| Disease | Colorectal Neoplasms | 3.70e-04 | 277 | 232 | 9 | C0009404 | |
| Disease | Gastric Adenocarcinoma | 4.31e-04 | 45 | 232 | 4 | C0278701 | |
| Disease | Amyloidosis, familial visceral | 6.06e-04 | 5 | 232 | 2 | C0268389 | |
| Disease | desmocollin-2 measurement | 6.06e-04 | 5 | 232 | 2 | EFO_0021936 | |
| Disease | Familial Exudative Vitreoretinopathy | 6.06e-04 | 5 | 232 | 2 | C0339539 | |
| Disease | intrahepatic cholestasis (biomarker_via_orthology) | 6.06e-04 | 5 | 232 | 2 | DOID:1852 (biomarker_via_orthology) | |
| Disease | basal cell carcinoma | 7.73e-04 | 189 | 232 | 7 | EFO_0004193 | |
| Disease | Sjogren's syndrome (is_marker_for) | 8.60e-04 | 24 | 232 | 3 | DOID:12894 (is_marker_for) | |
| Disease | Small cell carcinoma of lung | 8.65e-04 | 54 | 232 | 4 | C0149925 | |
| Disease | Amyloidosis, hereditary systemic | 9.04e-04 | 6 | 232 | 2 | cv:C4081731 | |
| Disease | Inhalant adrenergic use measurement | 9.84e-04 | 96 | 232 | 5 | EFO_0009941 | |
| Disease | Adenocarcinoma of large intestine | 9.84e-04 | 96 | 232 | 5 | C1319315 | |
| Disease | alpha fetoprotein measurement | 1.18e-03 | 100 | 232 | 5 | EFO_0010583 | |
| Disease | neuropilin-1 measurement | 1.26e-03 | 7 | 232 | 2 | EFO_0020603 | |
| Disease | response to opioid | 1.37e-03 | 61 | 232 | 4 | EFO_0008541 | |
| Disease | neutrophil count | CPAMD8 NUP210L BACH2 GCKR ZCCHC2 RRAGC DSTYK NBEAL2 NLRC5 PLCB2 DNAJC13 RBBP8 JMJD1C GTF3C1 ANKRD34A PTCD2 LRP4 FCRL5 STK40 STARD3NL LYZ SP7 | 1.41e-03 | 1382 | 232 | 22 | EFO_0004833 |
| Disease | carcinoma (implicated_via_orthology) | 1.64e-03 | 64 | 232 | 4 | DOID:305 (implicated_via_orthology) | |
| Disease | D dimer measurement | 1.67e-03 | 30 | 232 | 3 | EFO_0004507 | |
| Disease | female breast cancer (is_implicated_in) | 1.67e-03 | 8 | 232 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Large cell carcinoma of lung | 2.01e-03 | 32 | 232 | 3 | C0345958 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 2.14e-03 | 9 | 232 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | bringing up phlegm, sputum or mucus on most days, self-reported | 2.14e-03 | 9 | 232 | 2 | EFO_0009824 | |
| Disease | acquired immunodeficiency syndrome (is_implicated_in) | 2.14e-03 | 9 | 232 | 2 | DOID:635 (is_implicated_in) | |
| Disease | Malignant neoplasm of breast | ABCA4 ATP8B1 ABCB1 WDR53 MKI67 NLRC5 HERC2 TFAP2D DSC3 TCP1 YY2 HDAC7 ARAP3 LLGL1 ANKRD34A EXO1 DIP2C FCRL5 | 2.20e-03 | 1074 | 232 | 18 | C0006142 |
| Disease | adult onset asthma | 2.45e-03 | 118 | 232 | 5 | EFO_1002011 | |
| Disease | Endometrial Carcinoma | 2.52e-03 | 72 | 232 | 4 | C0476089 | |
| Disease | dry eye syndrome (is_marker_for) | 2.66e-03 | 10 | 232 | 2 | DOID:10140 (is_marker_for) | |
| Disease | cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 2.73e-03 | 121 | 232 | 5 | EFO_0008595, EFO_0020943 | |
| Disease | opioid dependence | 2.81e-03 | 237 | 232 | 7 | EFO_0005611 | |
| Disease | Macrocephaly | 3.23e-03 | 11 | 232 | 2 | C0221355 | |
| Disease | pars orbitalis volume measurement | 3.23e-03 | 11 | 232 | 2 | EFO_0010320 | |
| Disease | mismatch repair cancer syndrome (is_implicated_in) | 3.86e-03 | 12 | 232 | 2 | DOID:0112182 (is_implicated_in) | |
| Disease | Trigeminal Neuralgia | 3.86e-03 | 12 | 232 | 2 | C0040997 | |
| Disease | Secondary Trigeminal Neuralgia | 3.86e-03 | 12 | 232 | 2 | C0393787 | |
| Disease | Trigeminal Neuralgia, Idiopathic | 3.86e-03 | 12 | 232 | 2 | C0393786 | |
| Disease | alcohol consumption measurement, alcohol drinking | 3.86e-03 | 12 | 232 | 2 | EFO_0004329, EFO_0007878 | |
| Disease | hereditary spastic paraplegia (implicated_via_orthology) | 4.70e-03 | 43 | 232 | 3 | DOID:2476 (implicated_via_orthology) | |
| Disease | high grade glioma (implicated_via_orthology) | 5.01e-03 | 44 | 232 | 3 | DOID:3070 (implicated_via_orthology) | |
| Disease | ulcerative colitis | 5.24e-03 | 335 | 232 | 8 | EFO_0000729 | |
| Disease | autosomal dominant polycystic kidney disease (implicated_via_orthology) | 5.26e-03 | 14 | 232 | 2 | DOID:898 (implicated_via_orthology) | |
| Disease | cholesterol to total lipids in large VLDL percentage | 5.34e-03 | 45 | 232 | 3 | EFO_0022236 | |
| Disease | Alcoholic Intoxication, Chronic | 5.49e-03 | 268 | 232 | 7 | C0001973 | |
| Disease | aspartate aminotransferase measurement | ABCA4 ATP8B1 GCKR PHLDA2 ABCB1 CKB SETDB1 CLCN4 AP1B1 DSTYK NLRC5 IFT80 DNAJC13 NUBP2 LYZ | 5.52e-03 | 904 | 232 | 15 | EFO_0004736 |
| Disease | respiratory system disease | 5.89e-03 | 145 | 232 | 5 | EFO_0000684 | |
| Disease | liver volume | 6.04e-03 | 15 | 232 | 2 | EFO_0600048 | |
| Disease | hepcidin:transferrin saturation ratio | 6.04e-03 | 15 | 232 | 2 | EFO_0007902 | |
| Disease | Hereditary hearing loss and deafness | 6.06e-03 | 146 | 232 | 5 | cv:C0236038 | |
| Disease | resting heart rate | 6.59e-03 | 149 | 232 | 5 | EFO_0004351 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 6.77e-03 | 49 | 232 | 3 | EFO_0022256 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 6.87e-03 | 16 | 232 | 2 | C0751885 | |
| Disease | Intrahepatic cholestasis of pregnancy | 6.87e-03 | 16 | 232 | 2 | EFO_0009048 | |
| Disease | platelet component distribution width | NUP210L MTSS1 ZZEF1 CKB CLIC5 AP2B1 TESK2 MLH1 ATP13A3 GNAS SH3TC2 HDAC7 JMJD1C | 7.10e-03 | 755 | 232 | 13 | EFO_0007984 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 7.16e-03 | 152 | 232 | 5 | DOID:0060041 (implicated_via_orthology) | |
| Disease | response to cisplatin | 7.57e-03 | 51 | 232 | 3 | GO_0072718 | |
| Disease | cholesterol to total lipids in small VLDL percentage | 7.57e-03 | 51 | 232 | 3 | EFO_0022242 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 7.74e-03 | 17 | 232 | 2 | C0751883 | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 7.74e-03 | 17 | 232 | 2 | EFO_0004626, EFO_0004627 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IKANSEACRDGLRAV | 46 | Q10589 | |
| DKDDFLGRCKVRLTT | 726 | Q9BSJ8 | |
| LCDVTLIVERKEFRA | 36 | Q9BYV9 | |
| EREFRGLGDCLVKIT | 151 | P12236 | |
| FIELQGCSVRETKSR | 436 | Q8WWN8 | |
| DVDFVRKAVRAIGRC | 366 | P63010 | |
| QRRDIICVSKLGTEF | 931 | Q6UY14 | |
| SERALRKLCGAATGE | 301 | Q9BQT9 | |
| TIKVLEDRLRAGLCD | 76 | Q99708 | |
| KDIACSEALLERFII | 201 | P78363 | |
| SIKRLCIIESVFEGE | 216 | Q9H5V8 | |
| REGRAALITSFCVFK | 926 | Q9H7F0 | |
| VCFLLLRKTGRASDQ | 256 | Q3KPI0 | |
| GTAAAKGERCRSFIE | 126 | Q2KHT4 | |
| VHECVFKGDVRRLSS | 116 | Q8N6S4 | |
| RGLAVFISDIRNCKS | 11 | O95782 | |
| EEATGALTLTRKCFR | 151 | Q96P50 | |
| IGEAVFARCLSSLKD | 281 | P52209 | |
| SGRRIFTGSDDCLVK | 191 | Q6RI45 | |
| SSKEFKRAFVRILGC | 351 | P35368 | |
| CSDTRGLEIAIKQRV | 421 | Q96M93 | |
| DVDFVRKAVRAIGRC | 366 | Q10567 | |
| GCVITRDRKESLDVY | 291 | Q13510 | |
| ETVVDIFRKLGLRQC | 711 | P51793 | |
| EGKVTCDIRLRVRAE | 191 | Q8WXF8 | |
| TRAEIDLVCELAKRA | 806 | Q6UB35 | |
| RRKFLDGDELTLADC | 331 | Q9NZA1 | |
| IKETYGDTEAICRRL | 46 | Q01814 | |
| DKILLRGCVIRNTDF | 291 | O43520 | |
| CGKLLTLVSTRDFIE | 621 | Q9NRL2 | |
| RGLAVFISDIRNCKS | 11 | O94973 | |
| RGDRETLATLLDACK | 121 | Q69YU3 | |
| ALKSSCLDEQRRELG | 121 | Q7Z6R9 | |
| ACLKDTFERLGRDAE | 351 | Q9UF12 | |
| SVGDVRRELTFCRKT | 166 | Q9Y5Y2 | |
| RVFVDGLCRAKFESL | 76 | P53805 | |
| KIVRRVDCLLFGTTI | 96 | Q7Z4M0 | |
| DSTVGKSCLIRRFTE | 16 | Q96DA2 | |
| ALGRTRVKSSVCLEA | 236 | O94810 | |
| TKIGKESCFERIVSR | 511 | Q99504 | |
| ESCFERIVSRFGKKV | 516 | Q99504 | |
| FIDRAKKIDTISRAC | 421 | O75311 | |
| RVRKVALATFASVAC | 856 | Q15334 | |
| EALDKAREGRTCIVI | 1216 | P08183 | |
| KVIEVFIRAEDGLCR | 566 | Q08999 | |
| FTIIRKCISAVETRG | 396 | A1A4S6 | |
| SDCTLKILDFGLART | 161 | P45984 | |
| CRLTLLRSEKDGAAT | 12596 | Q8WXI7 | |
| CRLTLLRSEKDGAAT | 12751 | Q8WXI7 | |
| TIKAALSRVCGDRIF | 271 | P49441 | |
| QIRDCVIRILSGSKD | 301 | Q8NGI2 | |
| QESEAKALLRCVRFG | 151 | A6NCF5 | |
| ARKALDRCSEGSFLL | 201 | Q15233 | |
| CLASLFSGRLVRSDV | 751 | Q86WA8 | |
| VQGKVFERCELARTL | 16 | P61626 | |
| ICVATIRKVLADGFL | 401 | Q05BQ5 | |
| RILVCGRISLAKEVF | 191 | Q68DU8 | |
| CSRGERRAIEKLAVE | 146 | P12277 | |
| FGEVCLARKVDTKAL | 716 | O95835 | |
| IACAEKRFLILSRNG | 456 | O95714 | |
| VFLRTSEKAGSCFIR | 251 | O43861 | |
| EGRAVAVKRLLRECF | 541 | Q76MJ5 | |
| FVSTGRDTACVKALR | 281 | Q4FZB7 | |
| GKRFLCVAVGDEARS | 11 | Q15652 | |
| CKAGAEEVLLLARRT | 336 | O75197 | |
| RKAEGLDLASCVRSL | 151 | Q8NHQ9 | |
| RETECSRVGKQSFII | 86 | Q86X55 | |
| KRLFRSDGELSVCGQ | 36 | Q5SYE7 | |
| GFAEELSKCVQVRVR | 531 | P51805 | |
| KSVRCERGASISFSL | 331 | Q96RD9 | |
| SDCTLKILDFGLART | 161 | P45983 | |
| IASREERAKALITCV | 226 | Q9H339 | |
| KALIEERGRFCTFIS | 186 | O43312 | |
| FTTSNRIDREKLCAG | 86 | Q9HC56 | |
| TLFTDLERKGLLIAC | 536 | Q9Y233 | |
| CKRVAVEGVDVIFSR | 106 | A6NFU8 | |
| GTVIGSARCKDFRER | 81 | P08237 | |
| CLRKGILSFERSLEQ | 6 | A6NIU2 | |
| AVRALTCTLLREDFG | 51 | Q86W50 | |
| LSCKIADFGLARLIE | 376 | P06239 | |
| REDSRAGRLSFCTKV | 31 | A6NFX1 | |
| SSAFTVLAELRRCGL | 466 | P98088 | |
| IATRKGCEREVSSFL | 106 | Q07864 | |
| RSIRKADVEGELLAC | 1271 | P46013 | |
| GLVTSRDAFITAICK | 596 | Q7Z3U7 | |
| LLRKALTEECGRRSA | 486 | Q2M2Z5 | |
| CREALDVLAKTVAFL | 56 | Q15466 | |
| NARLSSIKTRFEGLC | 96 | Q8IZL8 | |
| FVGTLERCLQSLEKS | 491 | Q6XUX3 | |
| RLRTAGTICLETFKD | 456 | P15170 | |
| GASLADRLVRKCDVL | 36 | Q2TAA2 | |
| DFVGDACKAIASRVR | 566 | Q14764 | |
| VLAEGQRILTKSCRE | 341 | Q92832 | |
| RKCGDAFAEALSRSL | 696 | Q86WI3 | |
| ELARDCLTKSRDGLI | 226 | Q9Y2H9 | |
| FSGQSKARCIESLLR | 526 | Q14397 | |
| SVLRREIVSAAKVCG | 56 | Q96HP4 | |
| RGQLLKVSCEDTLFR | 181 | Q8NGU1 | |
| TENEIRGLCLKSREI | 31 | P62136 | |
| LDARTKGLDARAVCV | 86 | P60673 | |
| EAEVRGLCIKSREIF | 31 | P62140 | |
| KVAALSGDARRCLDI | 711 | Q13415 | |
| DALKCDVTSALREIR | 261 | P12036 | |
| QGREKDFIILSCVRA | 841 | Q92900 | |
| ACIRVAGKILESLDR | 216 | P0DPD8 | |
| LEVECATQLRRFGDK | 21 | Q13794 | |
| IVACIETLRKALSEF | 141 | Q14008 | |
| ASLVCKIADFGLARV | 391 | P08631 | |
| RDLCITSVKRFGKEE | 486 | Q9P2H3 | |
| DSRLFTDVIICVEGK | 61 | Q6TFL4 | |
| ICRKDFARDTGTEKL | 476 | O00341 | |
| DKIIGRVNLEECFRS | 46 | Q14574 | |
| KLDEVSIRAIGCFRE | 1261 | Q9H799 | |
| CSRGVDIKADIVFLV | 431 | Q99715 | |
| FSRFLKVCGSELVRL | 366 | Q9UKA2 | |
| EITKQRLLGDVSCRA | 191 | O60883 | |
| IRFDDCTDQLATRIK | 136 | Q9H5Z1 | |
| AERIFIELKFTVRDC | 91 | P29317 | |
| LVCKVSDFGLSRVLE | 751 | P29317 | |
| LRKAGRSAEEICRAI | 651 | Q8IVF7 | |
| RTTKILGSRDFDICV | 286 | Q8IZJ3 | |
| EVIIADFCFLRIRTK | 96 | Q8TDW7 | |
| CKLLRSREAAAAVDV | 1091 | Q9Y2E4 | |
| DLLRCRVLTSGIFET | 196 | P63092 | |
| KELERVIGDCRFVSA | 241 | Q9HBK9 | |
| KRADTVGLACEAINR | 2101 | O75165 | |
| VFCEKGVFDLDSTRR | 231 | Q96NU7 | |
| CTAFGKDVLKLVEAR | 826 | Q14974 | |
| FISDEKRVVGCLIAE | 481 | Q56NI9 | |
| RGSCSRALAREVDLK | 181 | P02671 | |
| VVACFDSLKGRCTRE | 51 | Q9NUK0 | |
| ILSVIGEFRDCISSR | 2056 | Q8TEP8 | |
| TLVSETIRRFGRLDC | 71 | Q9BPX1 | |
| RTKVAGIYRELCLES | 116 | Q5PSV4 | |
| GLKVCDSADRIRDTL | 576 | Q96QF7 | |
| IDFLESGKTNLRRCT | 306 | Q92841 | |
| CLRGRKASLEELQSV | 566 | Q8WUI4 | |
| IEGALCKDGRFRSDI | 221 | Q6SJ93 | |
| ECSRGERLSITLAKN | 36 | Q16099 | |
| SLISIRDEKDGINRC | 126 | Q13255 | |
| GARLALILCVTKARE | 16 | P31944 | |
| FCLRIFSEKKAITRD | 481 | O14815 | |
| AITCFTRGLDIRKEK | 31 | O43405 | |
| ACISLAKRVGFESLS | 216 | Q14147 | |
| LALVCFVREESFERK | 336 | Q9NQL2 | |
| ADRFGRKLCLLTTVL | 171 | O15244 | |
| RVLSFDIECAGRKGI | 311 | P28340 | |
| LFVRLSSTGKRICEI | 511 | Q9Y597 | |
| SLLSRAERESCKGLF | 181 | Q8IW40 | |
| RKLRECDGLVDALIF | 546 | O60716 | |
| LVLRIATDDSKAVCR | 151 | P11926 | |
| KAVCRLSVKFGATLR | 161 | P11926 | |
| LCRIGDKEGALTAFR | 111 | Q15008 | |
| IARCVFTESSKILLG | 46 | Q9H8Q6 | |
| REGAAFVSSRVLKCF | 1316 | Q5VU65 | |
| LKGEILSRRASCFAV | 231 | Q8WV60 | |
| IFTTGARIDREKLCA | 116 | Q9BZA8 | |
| LEEKTRECGTLARQL | 701 | Q5BJF6 | |
| LRGRSDADLVVFLSC | 811 | Q9Y6K5 | |
| HRKELSGVFRLCLTD | 246 | O14654 | |
| KRLTLSEICEFISGR | 146 | O60548 | |
| LDRDACDTVRVKALF | 196 | Q9NZL4 | |
| RRFSEECLSSLGKAL | 531 | Q9NZ71 | |
| REAFERDSKAVGLCE | 866 | Q5VT97 | |
| ARKTTCEFTGDILRT | 101 | P15313 | |
| SCQFVAVRRDTGEKL | 1376 | P07814 | |
| ALVCILREESFERKG | 336 | Q9HB90 | |
| IIFTAAREGRETLKC | 296 | Q8NFQ8 | |
| DGRVSENTVCLIRKL | 296 | Q8N2I9 | |
| ESLIKILARGFCVDD | 171 | P35499 | |
| GFVERLCKLATRKVS | 296 | Q8TEL6 | |
| CGKSTTERFDLARAL | 361 | Q86VH5 | |
| DILSRDGLQTCRFKV | 616 | Q9H0K6 | |
| GCVALITRLVSDRSK | 116 | Q8TBE7 | |
| RELSDISSARKLCGR | 21 | Q9Y581 | |
| SELTARGRKLEDECF | 946 | Q9Y2K3 | |
| LRCRVLTSGIFETKF | 841 | Q5JWF2 | |
| SEKLFEGVCSLLDRL | 1546 | Q6ZNJ1 | |
| LFVEAFTSRRCEVLK | 41 | A3QJZ6 | |
| LFLVDCGIRDSKLRV | 356 | A3QJZ6 | |
| ISLVERGCSESLKLF | 891 | Q5VXU9 | |
| SVISGYRLACKEAVR | 116 | P17987 | |
| CIKESLRIFIDLGET | 1026 | Q8TF17 | |
| SDGFCIIRTIDGKVL | 501 | Q8IZU2 | |
| ECVDDFRVVSLKLLR | 466 | Q9Y6Y8 | |
| FEELGKGAFSVVRRC | 16 | Q9UQM7 | |
| TGIRKEDLDIVCERF | 66 | P40692 | |
| REAIRELTGKLARCE | 81 | P47972 | |
| KERVLCLFDVDGTLT | 11 | Q92871 | |
| KGRCASLEEILSQRD | 266 | Q53GL0 | |
| GLCKTTFLLDAVRNR | 46 | O60518 | |
| LLREGKVSEARECFT | 106 | Q9UQ84 | |
| GRSELELLKLRSAEC | 16 | Q8IYS1 | |
| VRCSESRLSEEGIFL | 906 | O94855 | |
| DGSLVRILFLDDKRC | 371 | Q15047 | |
| TCARILLYRGADKDV | 361 | Q9Y566 | |
| TRFKTLFVAGERCDV | 416 | Q9H6R3 | |
| VAELSERKRRGSSLC | 31 | Q70JA7 | |
| LRRSLETKTGADVCR | 171 | Q86XI2 | |
| SVRCHKFLVSRVGED | 76 | P51788 | |
| YSDLSKGVLRCRTVE | 301 | Q8NE01 | |
| ILFKTRAFISRDCGS | 66 | Q7Z7L8 | |
| GELVESLKRFCASTR | 136 | Q9Y679 | |
| ELRFLGSCLEDLARK | 126 | Q9C0B9 | |
| KGFAEKCRLASRTDI | 206 | Q9BXU1 | |
| RFESLCAVLEERKGE | 216 | Q9BYV2 | |
| KVLLLRDESTLFVCG | 131 | Q9H3T3 | |
| KELETLRFGAINCRE | 231 | Q6P1L6 | |
| SSEKGRTKREFICSI | 641 | O95625 | |
| RFCDVTIVADSLKFR | 31 | Q9Y330 | |
| ADAVRFLGCFSDLRK | 716 | Q8IZQ1 | |
| VSRVLKDFLQDACRG | 466 | Q9NZQ8 | |
| VAVRDRVAFACKFLS | 611 | Q9NXC5 | |
| LEGRAARFDCKISGT | 1076 | Q15772 | |
| IVCKTARRDLFGLSV | 46 | Q6PCB7 | |
| EKTFARIIRGGCSEF | 91 | Q8NDV3 | |
| CGKRFTRSDELERHV | 331 | Q8TDD2 | |
| KGISDVRRTFCLFVT | 46 | O95772 | |
| LVFALVTDLRDVKCS | 751 | O15067 | |
| AECGKAFLESSKLRR | 286 | O15391 | |
| RGLFCDVTLIAGDTK | 26 | Q9P1Z0 | |
| AVRIVESCTLKDFAI | 446 | P08922 | |
| TCLERAKEFKTRLGI | 11 | O15492 | |
| VCDAKRKSFLRDIDG | 3676 | Q86WI1 | |
| IFSCGAEDGKVRIFR | 211 | Q7Z5U6 | |
| AEVKESVRACLRTCF | 1136 | Q00722 | |
| RFHSILKVDCVERTG | 51 | Q53GA4 | |
| SVVLERLCAAFEKKG | 1051 | Q8IUG5 | |
| KFCDVSLLVQGRELR | 46 | Q96C00 | |
| LRQFVKSRIGCSSDD | 631 | O43149 | |
| EECGKAFIRSSQLTR | 226 | Q8TAQ5 | |
| DTAGCLEVVRERKAL | 801 | Q5SXM2 | |
| RTIRREDLISFLCGK | 136 | Q14CZ0 | |
| CRVERFIEIGSGTSK | 196 | Q15633 | |
| RSVCLIGDKEQRAAF | 256 | O60264 | |
| ATGCFGIDKEELRRR | 1751 | Q12789 | |
| SRLTRLDDFTCEKIG | 51 | Q96S53 | |
| CLRDSNGRIILSKTF | 161 | Q96PF2 | |
| EECGKALIQFSTLTR | 161 | Q15940 | |
| ECGRTFIESLKLNIS | 246 | Q8NDW4 | |
| CSDRAAVEFLRKLAS | 1091 | A6NCI4 | |
| IDCIRAFREEAIKFS | 636 | P13010 | |
| VAKRGRDVALRCDSI | 31 | A0A1B0GX95 | |
| IRIVCRAEGSLKIFI | 3266 | Q5THJ4 | |
| VSELAECVRDFLRKT | 376 | P57678 | |
| TIEASRLDGSCRKVL | 1451 | O75096 | |
| DKLRSTGASFIRCIK | 656 | Q9UM54 |